Structure, Biosynthesis and Gene Regulation of Collagens in Cartilage and Bone

Dynamics of Bone and Cartilage Metabolism

Volumn , Issue , 2006, Pages 3-40

  von der Mark, Klaus ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882564866     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088562-6/50002-9     Document Type: Chapter

References (493)

1. Boskey A.L., Wright T.M., Blank R.D. Collagen and bone strength. J. Bone. Miner. Res. 1999, 14:330-335.
2. Kielty C.M., Grant M.E. The collagen family: structure, assembly, and organisation in the extracellular matrix. Connective Tissue and its Heritable Disorders 2002, 159-221. Wiley-Liss, New York. P.M. Royce, B. Steinmann (Eds.).
3. Bruckner P., van der Rest M. Structure and function of cartilage collagens. Microsc. Res. Tech. 1994, 28:378-384.
4. Eyre D. Collagen of articular cartilage. Arthritis Res. 2002, 4:30-35.
5. Niyibizi C., Eyre D.R. Structural characteristics of cross-linking sites in type V collagen of bone. Chain specificities and heterotypic links to type I collagen. Eur. J. Biochem. 1994, 224:943-950.
6. Mayne R., Brewton R.G. New members of the collagen superfamily. Curr. Opin. Cell Biol. 1993, 5:883-890.
7. Eyre D.R., Wu J.J., Fernandes R.J., Pietka T.A., Weis M.A. Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem. Soc. Trans. 2002, 30:893-899.
8. Ayad S., Evans H., Weiss J.B., Holt L. Type VI collagen but not type V collagen is present in cartilage. Collagen Rel. Res. 1984, 4:165-168.
9. Keene D.R., Engvall E.G.W. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J. Cell Biol. 1988, 107:1995-2006.
10. Horikawa O., Nakajima H., Kikuchi T., Ichimura S., Yamada H., Fujikawa K., Toyama Y. Distribution of type VI collagen in chondrocyte microenvironment: study of chondrons isolated from human normal and degenerative articular cartilage and cultured chondrocytes. J. Orthop. Sci. 2004, 9:29-36.
11. Poole C.A., Ayad S., Gilbert R.T. Chondrons from articular cartilage. V. Immunohistochemical evaluation of type VI collagen organisation in isolated chondrons by light, confocal and electron microscopy. J. Cell. Sci. 1992, 103:1101-1110.
12. von der Mark K., Sorokin L.M. Adhesive Glycoproteins. Connective Tissue and its Heritable Disorders 2002, 293-328. Wiley-Liss, New York. P.M. Royce, B. Steinmann (Eds.).
13. Mayne R., Burgeson R.E. Structure and Function of Collagen Types 1987, Academic Press, Inc, Orlando, FL. R.P. mecham (Ed.).
14. Bateman J.F., Lamandé S.R., Ramskans J.A.M. Collagen superfamily. Extrazellular Matrix 1996, Vol. 2:22-67. Harwood Acad. Pulls. W.D. Comper (Ed.).
15. van der Rest M., Garrone R. Collagen family of proteins. Faseb. J. 1991, 5:2814-2823.
16. Piez K.A. Molecular and aggregate structure of the collagens. Extracellular Matrix Biochemistry 1998, Elsevier. K.A. Piez, H. Reddi (Eds.).
17. Olsen B.R. New insights into the function of collagens from genetic analysis. Curr. Opin. Cell. Biol. 1995, 7:720-727.
18. Sandell L., Boyd C.D. Extracellular Matrix Genes 1990, Academic Press, San Diego, CA.
19. Chu M.L., Prockop D.J. Collagen: gene structure. Connective Tissue and its Heritable Disorders 2002, 223-248. Wiley-Liss, New York. B. Steinmann, P.M. Royce (Eds.).
20. Kivirikko K.I. Collagen biosynthesis: a mini-review cluster. Matrix Biol. 1998, 16:355-356.
21. Bornstein P., Sage H. Regulation of collagen gene expression. Prog. Nucleic. Acid. Res. Mol. Biol. 1989, 37:67-106.
22. McLaughlin S.H., Bulleid N.J. Molecular recognition in procollagen chain assembly. Matrix Biol. 1998, 16:369-377.
23. Prockop D.J., Sieron A.L., Li S.W. Procollagen N-proteinase and procollagen C-proteinase. Two, unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling. Matrix Biol. 1998, 16:399-408.
24. Johnson L.L., Dyer R., Hupe D.J. Matrix metalloproteinases. Curr. Opin. Chem. Biol. 1998, 2:466-471.
25. Murphy G., Reynolds J.J. Extracellular matrix degradation. Connective Tissue and its Heritable Disorders 2002, 343-384. Wiley-Liss, New York. P.M. Royce, B. Steinmann (Eds.).
26. Myllyharju J., Kivirikko K.I. Collagens and collagenrelated diseases. Ann. Med. 2001, 33:7-21.
27. Prockop D.J., Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 1995, 64:403-434.
28. Kuivaniemi H., Tromp G. Mutations in fibrillar collagens (types I, II, III, and XI) fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum. Mut. 1997, 9:300-315.
29. Royce P.M., Steinmann B. Connective tissue and its Heritable Disorders 2002, Wiley Liss, New York.
30. Koch M., Foley J.E., Hahn R., Zhou P., Burgeson R.E., Gerecke D.R., Gordon M.K. Alpha 1(XX) collagen, a new member of the collagen subfamily, fibril-associated collagens with interrupted triple helices. J. Biol. Chem. 2001, 276:23120-23126.
31. Koch M., Laub F., Zhou P., Hahn R.A., Tanaka S.., Burgeson R.E., Gerecke D.R., Ramirez F., Gordon M.K. Collagen XXIV, a vertebrate fibrillar collagen with structural, features of invertebrate collagens: selective expression in developing cornea and bone. J. Biol. Chem. 2003, 278:43236-43244.
32. Koch M., Schulze J., Hansen U., Ashwodt T., Keene D.R., Brunken W.J., Burgeson R.E., Bruckner P., Bruckner-Tuderman L. A novel marker of tissue junctions, collagen XXII. J. Biol. Chem. 2004, 279:22514-22521.
33. Chou M.Y., Li H.C. Genomic organization and characterization of the human type XXI collagen (COL21A1) gene. Genomics 2002, 79:395-401.
34. Banyard J., Bao L., Zetter B.R. Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells. J. Biol Chem. 2003, 278:20989-20994.
35. Hashimoto T., Wakabayashi T., Watanabe A., Kowa H., Hosoda R., Nakamura A., Kanazawa I., Arai T., Takio K., Mann D.M., Iwatsubo T. CLAC: anovel Alzheimer amyloid plaque component derived from a transmembrane precursor CLAC-P/collagen type XXV. Embo. J. 2002, 21:1524-1534.
36. Sato K., Yomogida K., Wada T., Yorihuzi T., Nishimune Y., Hosokawa N., Nagata K. Type XXVI collagen, a new member of the collagen family, is specifically expressed in the testis and ovary. J. Biol. Chem. 2002, 277:37678-37684.
37. Boot-Handford R.P., Tuckwell D.S., Plumb D.A., Rock C.F., Poulsom R. A novel and highly conserved collagen (pro(alpha)l (XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J. Biol. Chem. 2003, 278:31067-31077.
38. Brodsky B., Ramshaw J.A. The collagen triple-helix structure. Matrix Biol. 1997, 15:545-554.
39. Berisio R., Vitagliano L., Mazzarella L., Zagari A. Recent progress on collagen triple helix structure, stability and assembly. Protein Pept. Lett. 2002, 9:107-116.
40. Mizuno K., Hayashi T., Peyton D.H., Bachinger H.P. Hydroxylation-induced stabilization of the collagen triple helix. Acetyl-(glycyl-4(R)-hydroxyprolyl-4(R)-hydroxyprolyl)(10)-NH(2) froms a highly stable triple helix. J. Biol. Chem. 2004, 279:38072-38078.
41. Hofmann H., Fietzek P.P., Kuhn K. The role of polar and hydrophobic interactions for the molecular packing of type 1 collagen: a three-dimensional evaluation of the amino acid sequence. J. Mol. Biol. 1978, 125:137-165.
42. Berg R.A., Prockop D.J. The thermal transition of a nonhydroxylated from of collagen. Evidence fora role for hydroxyproline in stabilizing the triple-helix of collagen. Biochem. Biophys. Res. Commun. 1973, 52:115-120.
43. Schmid T.M., Linsenmayer T.F. Denaturation-renaturation properties of two molecular forms of short-chain cartilage collagen. Biochem. 1984, 23:553-558.
44. Risteli J., Baechinger H.P., Engel J., Furthmayr H., Timpl R. 7S-collagen: characterization of an unusual basement membrane structure. Eur. J. Biochem. 1980, 108:239-250.
45. Kuehn K., Wiedemann H., Timpl R., Risteli J., Dieringer H., Voss T., Glanville R. Macromolecular structure of basement membrane collagen. FEBS Lett. 1981, 125:123-128.
46. Bruckner P., Prockop D.J. Proteolytic enzymes as probes for the triple-helical conformation of procollagen. Analyt. Biochem. 1981, 110:360-368.
47. Kodama T., Doi T., Suzuki H., Takahashi K., Wada Y., Gordon S. Collagenous macrophage scavenger receptors. Curr. Opin. Lipidol. 1996, 7:287-291.
48. Elomaa O., Sankala M., Pikkarainen T., Bergmann U., Tuuttila A., Raatikainen-Ahokas A., Sariola H., Tryggvason K. Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J. Biol. Chem. 1998, 273:4530-4538.
49. Fessler J.H., Doege K.J., Duncan K.G., Fessler L.I. Biosynthesis of collagen. J. Cell Biochem. 1985, 28:31-37.
50. Fessler J.H., Shigaki N., Fessler L.I. Biosynthesis and properties of procollagens V. Ann. Acad. Sci. N.Y. 1985, 460:181-186.
51. Fleischmajer J.S., Perlish J.S., Olsen B.R. Amino and carboxyl propeptides in bone collagen fibrils during embryogenesis. Cell Tissue Res. 1987, 247:105-109.
52. Kadler K.E., Hojima Y., Prockop D.J. Assembly of collagen fibrils de novo by cleavage of the type 1 PC-collagen with procollagen C-proteinase-assay of critical concentration demonstrates that collagen self-assembly is a classical example of an entropy-driven process. J. Biol. Chem. 1987, 262:15696-15701.
53. Hinek A., Reiner A., Poole R. The calcification of cartilage matrix in chondrocyte culture: Studies of the C-propetide of type II collagen (chondrocalcin). J. Cell Biol. 1987, 104:1435-1441.
54. Bogin O., Kvansakul M., Rom E., Singer J., Yayon A., Hohenester E. Insight into Schmid metaphyseal chondrodysplasia from the crystal structure of the collagen X NC1 domain trimer. Structure 2002, 10:165-173.
55. Schmid T.M., Cole A.A., Chen Q., Bonen D.K., Luchene L., Linsenmayer T. Assembly of type X collagen by hypertrophic chondrocytes. Extracellular Matrix Assembly and Structure 1994, 171-206. Academic Press. P. Yurchenco, D. Birk, R. Mecham (Eds.).
56. Frischholz S., Beier F., Girkontaite I., Wagner K., Pöschl E., Turnay J., Mayer U., von der Mark K. Characterization of human type X procollagen and its NC-1 domain expressed as recombinant proteins in HEK293 cells. J. Biol. Chem. 1998, 273:4547-4555.
57. Shaw L.M., Olsen B.R. FACIT collagens diverse molecular bridges in extracellular matrices. Trends. Biochem. Sci. 1991, 16:191-194.
58. Oh S.P., Warman M.L., Seldin M.F., Cheng S.D., Knoll J.H., Timmons S., Olsen B.R. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1 (XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 1994, 19:494-499.
59. Yamagata M., Yamada K.M., Yamada S.S., Shinomura T., Tanaka H., Nishida Y., Obara M., Kimata K. The complete primary structure of type XII collagen shows a chimeric molecule with reiterated fibronectin type III motifs, von Willebrand factor A motifs, a domain homologous to a noncollagenous region of type IX collagen, and short collagenous domains with an Arg-Gly-Asp site. J. Cell Biol. 1991, 115:209-221.
60. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
61. Hagg P., Rehn M., Huhtala P., Vaisanen T., Tamminen M., Pihlajaniemi T. Type XIII collagen is identified as a plasma membrane protein. J. Biol. Chem. 1998, 273:15590-15597.
62. Pihlajaniemi T., Tamminen M. The alphal chain of type XIII collagen consists of three collagenous and four non-collagenous domains, and its primary transcript undergoes complex alternative splicing. J. Biol. Chem. 1990, 265:16922-16928.
63. Gordon M.K., Fitch J.M., Foley J.W., Gerecke D.R., Linsenmayer C., Birk D.E., Linsenmayer T.F. Type XVII collagen (BP 1 80) in the developing avian cornea. Invest. Ophthalmol. Vis. Sci. 1997, 38:153-166.
64. Farjanel J., Schurmann G., Bruckner P. Contacts with fibrils containing collagen I, but not collagens II, IX, and XI, can destabilize the cartilage phenotype of chondrocytes. Osteoarthritis Cartilage 2001, 9:S55-S63.
65. Tulla M., Pentikainen O.T., Viitasalo T., Kapyla J., Impola U., Nykvist P., Nissinen L., Johnson M.S., Heino J. Selective binding of collagen subtypes by integrin alpha 11, alpha 21, and alpha 101 domains. J. Biol. Chem. 2001, 276:48206-48212.
66. Tiger C.F., Fougerousse F., Grundstrom G., Velling T., Gullberg D. Alphal 1 betal integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev. Biol. 2001, 237:116-129.
67. Jokinen J., Dadu E., Nykvist P., Kapyla J., White D.J., Ivaska J., Vehvilainen P., Reunanen H., Larjava H., Hakkinen L., Heino J. Integrin-mediated cell adhesion to type 1 collagen fibrils. J. Biol. Chem. 2004, 279:31956-31963.
68. Aszodi A., Bateman J.F., Gustafsson E., Boot-Handford R., Fassler R. Mammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice. Cell. Struct. Funct. 2000, 25:73-84.
69. Aszodi A., Chan D., Hunziker E., Bateman J.F., Fassler R. Collagen II is essential for the removal of the notochord and the formation of intervertebral discs [In Process Citation]. J. Cell Biol. 1998, 143:1399-1412.
70. Hagg R., Hedbom E., Mollers U., Aszodi A., Fassler R., Bruckner P. Absence of the alphal(IX) chain leads to a functional knock-out of the entire collagen IX protein in mice. J. Biol. Chem. 1997, 272:20650-20654.
71. Cheah K.S., Lau E.T., Au P.K., Tam P.P. Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. Development 1991, 111:945-953.
72. von der Mark K., von der Mark H., Timpl R., Trelstad R.L. Immunofluorescent localiz ation of collagen type-1, type-2 and type-3 in embryonic chick eye. Dev. Biol. 1977, 59:75-85.
73. Linsenmayer T.F., Smith G.N., Hay E.D. Synthesis of 2 collagen types by embryonic chick corneal epithelium in vitro. P. Nas. US 1977, 74:39-43.
74. Hay E.D. Collagen and embryonic development. Cell biology of extracellular matrix 1981, 379-409. Plenum Press, N.Y. E.D. Hay (Ed.).
75. von der Mark H., von der Mark K., Gay S. Study of differential collagen synthesis during development of the chick embryo by immunofluorescence. I. Preparation of collagen type I and type II specific antibodies and their application to early stages of the chick embryo. Develop. Biol. 1976, 48:237-249.
76. Niyibizi C., Eyre D.R. Bone type V collagen: chain composition and location of a trypsin cleavage site. Connect. Tissue Res. 1989, 20:247-250.
77. Hulmes D.J. The collagen superfamily-diverse structutes and assemblies. Essays. Biochem. 1992, 27:49-67.
78. Ramachandran G.N. Stereochemistry of collagen. Int. J. Pept. Protein Res. 1988, 31:1-16.
79. Adachi E., Hayashi T. In vitro formation of fine fibrils with a D-periodic banding pattern from type V collagen. Collagen Rel. Res. 1985, 5:225-232.
80. Birk D.E. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibnl assembly. Micron. 2001, 32:223-237.
81. Glimcher M.J., Shapiro F., Ellis R.D., Eyre D.R. Changes in tissue morphology and collagen composition during the repair of cortical bone in the adult chicken. J. Bone Am V. 1980, 62:964-973.
82. Lees S. Mineralization of type I collagen. Biophys. J. 2003, 85:204-207.
83. Giraud-Guille M.M., Besseau L., Martin R. Liquid crystalline assemblies of collagen in bone and in vitro systems. J. Biomech. 2003, 36:1571-1579.
84. Tromp G., Kuivaniemi H., Stacey A., Shikata H., Baldwin C.T., Jaenisch R., Prockop D.J. Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of human type 1 procollagen. Biochem. J. 1988, 253:633-640.
85. Kuivaniemi H., Tromp G., Chu M.L., Prockop D.J. Structure of a full-length cDNA clone for the prepro alpha 2(I) chain of human type 1 procollagen. Comparison with the chicken gene confirms unusual patterns of gene conservation. Biochem. J. 1988, 252:633-640.
86. Gerstenfeld L.C., Chipman S.D., Kelly C.M., Hodgens K.J., Lee D.D., Landis W.J. Collagen expression, ultrastructural assembly, and mineralization in cultures of chicken embryo osteoblasts. J. Cell Biol. 1988, 106:979-989.
87. Kratochwil K., Ghaffari-Tabrizi N., Holzinger I., Harbers K. Restricted expression of Mov 13 mutant alpha 1(I) collagen gene in oste oblasts and its consequences for bone development. Dev. Dyn. 1993, 198:273-283.
88. Fleischmajer R., MacDonald E.D., Perlish J.S., Burgeson R.E., Fisher L.W. Dermal collagen fibrils are hybrids of type 1 and type III collagen molecules. J. Struct. Biol. 1990, 105:162-169.
89. Birk D.E., Fitch J.M., Babiarz J.P., Linsenmayer T.F. Collagen type I and type V are present in the same fibril in the avian corneal stroma. J. Cell Biol. 1988, 106:999-1008.
90. von der Mark K. Localization of collagen types in tissues. Int. Rev. Conn. Tissue Res. 1981, 9:265-324.
91. Byers P.H. Osteogenesis imperfecta: perspectives and opportunities. Curr. Opin. Pediatr. 2000, 12:603-609.
92. Brenner R.E., Vetter U., Nerlich A., Wordorfer O., Teller W.M., Muller P.K. Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient ovemodification in collagen types 1 and III. J. Clin. Invest. 1989, 84:915-921.
93. Rao V.H., Steinmann B., de Wet W., Hollister D.W. Decreased thermal denaturation temperature of osteogenesis imperfacta mutant collagen is independent of post-translational overmodifications of ly sine and hydroxylysine. J. Biol. Chem. 1989, 264:1793-1798.
94. Montesano R., Schaller C., Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 1991, 66:697-711.
95. Emsley J., Knight C.G., Farndale R.W., Barnes M.J., Liddington R.C. Structural basis of collagen recognition by integrin alpha2betal. Cell 2000, 101:47-56.
96. Brakebusch C., Fassler R. The integrin-actin connection, an etemal love affair. Embo. J. 2003, 22:2324-2333.
97. DeMali K.A., Wennerberg K., Burridge K. Integrin signaling to the actin cytoske leton. Curr. Opin. Cell Biol. 2003, 15:572-582.
98. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
99. Velling T., Risteli J., Wennerberg K., Mosher D.F., Johansson S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11 beta 1 and alpha 2beta 1. J. Biol. Chem. 2002, 277:37377-37381.
100. Still J., Glat P., Silverstein P., Griswold J., Mozingo D. The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 2003, 29:837-841.
101. Ueda H., Hong L., Yamamoto M., Shigeno K., Inoue M., Toba T., Hoshitani M., Nakamura T., Tabata Y., Shimizu Y. Use of collagen sponge incorporating transforming growth factor-betal to promote bone repair in skull defects in rabbits. Biomaterials 2002, 23:1003-1010.
102. Yamanouchi K., Satomura K., Gotoh Y., Kitaoka E., Tobiume S., Kume K., Nagayama M. Bone formation by transplanted human osteoblasts cultured within collagen sponge with dexamethasone in vitro. J. Bone Miner. Res. 2001, 16:857-867.
103. Jaenisch R., Harbers K., Schnieke A., Lohler J., Chumakov I., Jahner D., Grotkopp D., Hoffmann E. Germline integration of moloney murine leukemia virus at the Movl3 locus leads to recessive lethal mutation and early embryonic death. Cell 1983, 32:209-216.
104. Hartung S., Jaenisch R., Breindl M. Retrovirus insertion inactivates mouse alpha 1(I) collagen gene by blocking initiation of transeription. Nature 1986, 320:365-367.
105. Kratochwil K., Dziadek M., Lohler J., Harbers K., Jaenisch R. Normal epithelial branching morphogenesis in the absence of collagen I. Dev. Biol. 1986, 117:596-606.
106. Schwarz M., Harbers K., Kratochwil K. Transcription of a mutant collagen-I gene is a cell type and stage-specific marker for odontoblast and osteoblast differentiation. Development 1990, 108:717-726.
107. Kratochwil K., von der Mark K., Kollar E.J., Jaenisch R., Mooslehner K., Schwarz M., Haase K., Gmacht I., Harbers K. Retrovirus-induced insertional mutation in Mov13 mice affects collagen-I expression in a tissue-specific manner. Cell 1992, 57:807-816.
108. Burgeson R.E., Hebda P.A., Morris N.P., Hollister D. Human cartilage collagens. Comparison of cartilage collagens with human type V collagen. J. Biol. Chem. 1982, 257:7852-7856.
109. Burgeson R.E., Hollister D. Collagen hetero geneity in human cartilage: identification of several new collagen chains. Biochem. Biophys. Res. Commun. 1979, 87:1124-1131.
110. Zhidkova N.I., Brewton R.G., Mayne R. Molecular cloning of PARP (proline/arginine-rich protein) from human cartilage and subsequent demonstration that PARP is a fragment of the NH2-terminal domain of the collagen alpha 2(XI) chain. FEBS Lett. 1993, 326:25-28.
111. Fessler L., Kumamoto C., Meis M., Fessler J. Assembly and processing of procollagen V (AB) in chick blood vessels and other tissues. J. Biol. Chem. 1981, 256:9640-9645.
112. Fessler L.I., Brosh S., Chapin S., Fessler J.H. Tyrosine sulfation in precursors of collagen V. J. Biol. Chem. 1986, 261:5034-5040.
113. Wu J.J., Lark M.W., Chun L.E., Eyre D.R. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J. Biol. Chem. 1991, 266:5625-5628.
114. Haralson M.A., Mitchell W.M., Rhodes R.K., Kresina T.F., Gay R., Miller E.J. Chinese hamster lung cells synthesize and confine to the cellular domain a collagen composed solely of B chains. Proc. Natl. Acad. Sci. USA 1980, 77:5206-5210.
115. Eyre D., Wu J.-J. Type XI or lalpha, 2alpha, 3alpha collagen. Stucture and Function of Collagen Types 1987, 261-281. R. Mayne, R.E. Burgeson (Eds.).
116. Niyibizi C., Eyre D.R. Identification of the cartilage alpha 1(XI) chain in type V collagen from bovine bone. FEBS Lett 1989, 242:314-318.
117. Mayne R., Brewton R.G., Mayne P.M., Baker J.R. Isolation and characterization of the chains of type V/type XI collagen present in bovine vitreous. J. Biol. Chem. 1993, 268:9381-9386.
118. von der Mark K., Oecalan M. Immunofluorescent localization of type V collagen in the chick embryo with monoclonal antibodies. Collagen Rel. Res. 1982, 2:541-555.
119. Linsenmayer T.F., Fitch J.M., Schmid T.M., Zak N.B., Gibney E., Sanderson R.D., Mayne R. Mon oclonal antibodies against chicken type V collagen: Production, specificity, and use for immunocytochemical localization in embryonic cornea and other organs. J. Cell Biol. 1983, 96:124-132.
120. Mayne R. Cartilage collagens-what is their function, and are they involved in articular disease. Arthritis Rheumatism 1989, 32:241-246.
121. von der Mark K., von der Mark H. Role of 3 genetically distinct collagen types in endochondral ossification and calcification of cartilage. J. Bone Joint Res. 1977, 59:458-464.
122. Eyre D.R., Brickley-Parsons D.M., Glimcher M.J. Predominance of type 1 collagen at the surface of avian articular cartilage. FEBS Lett. 1978, 85:259-263.
123. Goldwasser M., Astley T., van der Rest M., Glorieux F.H. Analysis of the type of collagen present in osteoarthritic human cartilage. Clin. Orthop. Rev. Res. 1982, 167:296-302.
124. Ronziere M.C., Ricard-Blum S., Tiollier J., Hartmann D.J., Garrone R., Herbage D. Comparative analysis of collagens solubilized from human foetal, and normal and osteoarthritic adult articular cartilage, with emphasis on type VI collagen. Biochim. Biophys. Acta 1990, 1038:222-230.
125. Aigner T., Bertling W., Stöb H., Weseloh G., von der Mark K. Independent expression of fibril-forming collagens I, II, and III in chondrocytes in human osteoarthritic cartilage. J. Clin. Invest. 1993, 91:829-837.
126. Wotton S.F., Duance V.C. Type III collagen in normal human articular cartilage. Histochem. J. 1994, 26:412-416.
127. Young R.D., Lawrence P.A., Duance V.C., Aigner T., Monaghan P. Immunolocalization of collagen types II and III in single fibrils of human articular cartilage. J. Histochem. Cytochem. 2000, 48:423-432.
128. Eerola I., Salminen H., Lammi P., Lammi M., von der Mark K., Vuorio E., Saamanen A.M. Type X collagen, a natural component of mouse articular cartilage: association with growth, aging, and osteoarthritis. Arthritis Rheum 1998, 41:1287-1295.
129. Lammi P.E., Lammi M.J., Hytinen M.M., Panula H., Kiviranta I., Helminen H.J. Site-specific immunostaining for type X collagen in noncalcified articular cartilage of canine stifle knee joint. Bone 2002, 31:690-696.
130. Rucklidge G.J., Milne G., Robins S.P. Collagen type X: a component of the surface of normal human, pig, and rat articular cartilage. Biochem. Biophys. Res. Commun. 1996, 224:297-302.
131. von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Glueckert K., Stoess H. Type X collagen synthesis in human osteoarthritic cartilage: Indication of chondrocyte hypertrophy. Arthritis Rheum. 1992, 35:806-811.
132. Aigner T., Reichenberger E., Bertling W., Kirsch T., Stöb H., von der Mark K. Type X collagen expression in osteoarthritic and rheumatoid articular cartilage. Virchows Arch. 1993, 63:205-211.
133. Kwan K.M., Pang M.K., Zhou S., Cowan S.K., Kong R.Y., Pfordte T., Olsen B.R., Sillence D.O., Tam P.P., Cheah K.S. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J. Cell Biol. 1997, 136:459-471.
134. Jacenko O., Chan D., Franklin A., Ito S., Underhill C.B., Bateman J.F., Campbell M.R. A dominant interference collagen X mutation disrupts hypertrophic chondrocyte pericellular matrix and glycosaminoglycan and proteoglycan distribution in transgenic mice. Am. J. Pathol. 2001, 159:2257-2269.
135. Jacenko O., Roberts D.W., Campbell M.R., McManus P.M., Gress C.J., Tao Z. Linking hematopoiesis to endochondral skeletogenesis through analysis of mice transgenic for collagen X. Am. J. Pathol. 2002, 160:2019-2034.
136. Topping R.E., Bolander M.E., Balian G. Type X collagen in fracture callus and the effects of experimental diabetes. Clin. Orthop 1994, 308:220-228.
137. Trelstad R.L., Kang A.H., Igarashi S., Gross J. Isolation of two distinct collagens from chick cartilage. Biochemistry 1970, 9:4993-4998.
138. Miller E.J. Isolation and characterization of a collagen from chick cartilage containing three identical alpha chains. Biochemistry 1971, 10:1652-1659.
139. Ryan M.C., Sandell L.J. Differential expression of a cysteine-rich domain in the amino-teminal propeptide of type II procollagen by alternative splicing of messenger-RNA. J. Biol. Chem. 1990, 265:10334-10339.
140. Sandell L.J., Nalin A.M., Reife R.A. Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev. Dyn. 1994, 199:129-140.
141. Madsen K., Moskalewski S., von der Mark K., Friberg U. Synthesis of proteoglycans, collagen, and elastin by cultures of rabbit auricular chondrocytes-relation to age of the donor. Dev. Biol. 1983, 96:63-73.
142. Eyre D.R., Muir H. Types I and II collagens in intervertebral disc. Insterchanging radial distributions in annulus fibrosus. Biochem. J. 1976, 157:267-270.
143. Yang C.L., Rui H., Mosler S., Notbohm H., Sawaryn A., Muller P.K. Collagen II from articular cartilage and annulus fibrosus Structural and functional implication of tissue specific posttranslation modifications of collagen molecules. Eur. J. Biochem. 1993, 213:1297-1302.
144. Newsome D.A., Linsenmayer T.F., Trelstad R.L. Vitreous body collagen. Evidence for a dual origin from the neural retina and hyalocytes. J. Cell Biol. 1976, 71:59-67.
145. Trelstad R.L., Kang A.H. Collagen heterogeneity in the avian eye: lens, vitreous body, cornea and sclera. Exp. Eye Res. 1974, 18:395-406.
146. Thorogood P., Bee J., von der Mark K. Transient expression of collagen type II at epitheliomesenchymal interfaces during morphogenesis of the cartilaginous neurocranium. Develop. Biol. 1986, 116:497-509.
147. Wood A., Ashhurst D.E., Corbett A., Thorogood P. The transient expression of type II collagen at tissue interfaces during mammalian craniofacial development. Development 1991, 111:955-968.
148. Mundlos S., Olsen B.R. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. Faseb. J. 1997, 11:227-233.
149. Spranger J., Winterpacht A., Zabel B. The type II collagenopathies: a spectrum of chondrodysplasias. Eur. J. Pediatr. 1994, 153:56-65.
150. Byers P.H. Molecular genetics of chondrodysplasias, including clues to development, structure, and function. Curr. Opin. Rheumatol. 1994, 6:345-350.
151. Chan D., Cole W.G., Chow C.W., Mundlos S., Bateman J.F. COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen type I and III collagens in cartilage. J. Biol. Chem. 1995, 270:1747-1753.
152. Mundlos S., Chan D., McGill J., Bateman J.F. An alpha I(II) Gly 913 to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis. Am. J. Med. Genet. 1996, 63:129-136.
153. Aszodi A., Hunziker E.B., Olsen B.R., Fassler R. The role of collagen II and cartilage fibril-associated molecules in skeletal development. Osteoarthritis Cartilage 2001, 9(Suppl A):S150-S159.
154. Conrad G.W., Kelly P.T., von der Mark K., Edelhauser H.F. A comparative study of elasmobranch corneal and scleral collagens. Expt. Eye Res. 1981, 32:659-672.
155. Holmdahl R., Malmstrom V., Vuorio E. Autoimmune recognition of cartilage collagens. Ann. Med. 1993, 25:251-264.
156. Stuart J.M., Watson W.C., Kang A.H. Collagen autoimmunity and arthritis. Faseb. J. 1988, 2:2950-2956.
157. Watson W.C., Cremer M.A., Wooley P.H., Townes A.S. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum. 1986, 29:1316-1321.
158. Holmdahl R., Andersson M., Goldschmidt T.J., Gustafsson K., Jansson L., Mo J.A. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev. 1990, 118:193-232.
159. Andersson M., Cremer M.A., Terato K., Burkhardt H., Holmdahl R. Analysis of type II collagen reactive T cells in the mouse. II. Different localization of immunodominant T cell epitopes on heterologous and autologous type II collagen. Scand. J. Immunol. 1991, 33:505-510.
160. Schulte S., Unger C., Mo J.A., Wendler O., Bauer E., Frischholz S., von der Mark K., Kalden J.R., Holmdahl R., Burkhardt H. Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J. Biol. Chem. 1998, 273:1551-1561.
161. Burkhardt H., Koller T., Engstrom A., Nandakumar K.S., Turnay J., Kraetsch H.G., Kalden J.R., Holmdahl R. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 2002, 46:2339-2348.
162. Backlund J., Carlsen S., Hoger T., Holm B., Fugger L., Kihlberg J., Burkhardt H., Holmdahl R. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2002, 99:9960-9965.
163. Morris N.P., Baechinger H.P. Type XI collagen is a heterotrimer with the composition (1alpha, 2alpha, 3alpha) retaining non-triple-helical domains. J. Biol. Chem. 1987, 262:11345-11350.
164. Wu J.J., Eyre D.R. Structural analysis of cross-linking domains in cartilage type XI collagen. Insights on polymeric assembly. J. Biol. Chem. 1995, 270:18865-18870.
165. Oxford J.T., DeScala J., Morris N., Gregory K., Medeck R., Irwin K., Oxford R., Brown R., Mercer L., Cusack S. Interaction between amino propeptides of type XI procollagen alpha1 chains. J. Biol. Chem. 2004, 279:10939-10945.
166. Davies G.B., Oxford J.T., Hausafus L.C., Smoody B.F., Morris N.P. Temporal and spatial expression of alternative splice-forms of the alphal(XI) collagen gene in fetal rat cartilage. Dev. Dyn. 1998, 213:12-26.
167. Lui V.C.H., Ng L.J., Sat E.W.Y., Nicholls J., Cheah K.S.E. Extensive alternative splicing within the amino-propeptide coding domain of alpha2(XI) procollagen mRNAs Expression of transcripts encoding truncated pro-alpha chains. J. Biol. Chem. 1996, 271:16945-16951.
168. Tsumaki N., Kimura T. Differential expression of an acidic domain in the amino-terminal propeptide of mouse pro-alpha 2(XI) collagen by complex alternative splicing. J. Biol. Chem. 1995, 270:2372-2378.
169. Neame P.J., Young C.N., Treep J.T. Isolation and primary structure of PARP, a 24-kDa proline- and arginine-rich protein from bovine cartilage closely related to the NH2-terminal domain in collagen alpha 1 (XI). J. Biol. Chem. 1990, 265:20401-20408.
170. Mendler M., Eich-Bender S.G., Vaughan L., Winterhalter K.H., Bruckner P. Cartilage contains mixed fibrils of collagen types II, IX and XI. J. Cell Biol. 1989, 108:191-197.
171. Blaschke U.K., Eikenberry E.F., Hulmes D.J., Galla H.J., Bruckner P. Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J. Biol. Chem. 2000, 275:10370-10378.
172. Gregory K.E., Oxford J.T., Chen Y., Gambee J.E., Gygi S.P., Aebersold R., Neame P.J., Mechling D.E., Bachinger H.P., Morris N.P. Structural organization of distinct domains within the non-collagenous N-terminal region of collagen type XI. J. Biol. Chem. 2000, 275:11498-11506.
173. Li Y., Lacerda D.A., Warman M.L., Beier D.R., Yoshioka H., Ninomiya Y., Oxford J.T., Morris N.P., Andrikopoulos K., Ramirez F. A fibrillar collagen gene, Collial, is essential for skeletal morphogenesis. Cell 1995, 80:423-430.
174. Vikkula M., Mariman E.C., Lui V.C., Zhidkova N.I., Tiller G.E., Goldring M.B., van Beersum S.E., de Waal Malefijt M.C., van den Hoogen F.H., Ropers H.H. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995, 80:431-437.
175. Shimokomaki M., Duance V.C., Bailey A.J. Identification of a new disulphide bonded collagen from cartilage. FEBS Lett. 1980, 121:51-54.
176. Reese C.A., Mayne R. Minor collagens of chicken hyaline cartilage. Biochem. 1981, 20:5443-5448.
177. Ninomiya Y., Olsen B.R. Synthesis and characterization of cDNA encoding a cartilage-specific short collagen. Proc. Natl. Acad. Sci. USA 1984, 81:3014-3018.
178. von der Mark K., van Menxel M., Wiedemann H. Isolation and characterization of a precursor form of M-collagen from embryonic chicken cartilage. Eur. J. Biochem. 1984, 138:629-633.
179. Mayne R., von der Mark K. Collagens of cartilage. Biochem. Cartilage 1983, 1:181-214.
180. van der Rest M., Mayne R., Ninomiya Y., Seidah N.G., Chretien M., Olsen B.R. The structure of type IX collagen. J. Biol. Chem. 1985, 260:220-225.
181. Vaughan L., Mendler M., Huber S., Bruckner P., Winterhalter K.H., Irwin M.L., Mayne R. D-periodic distribution of collagen type IX along cartilage fibrils. J. Cell Biol. 1988, 106:998.
182. van der Rest M., Mayne R. Type IX collagen proteoglycan from cartilage is covalently cross-linked to type II collagen. J. Biol. Chem. 1988, 263:1615-1618.
183. Wu J.J., Woods P.E., Eyre D.R. Identification of cross-linking sites in bovine cartilage type IX collagen reveals an antiparallel type II-type IX molecular relationship and type IX to type IX bonding. J. Biol. Chem. 1992, 267:23007-23014.
184. Vaughan L., Winterhalter K.H., Bruckner P. Proteoglycan Lt from chicken embryo sternum identified as type IX collagen. J. Biol. Chem. 1985, 260:4758-4763.
185. Noro A., Kimata K., Oike Y., Shinomura T., Maeda N., Yano S., Takahashi N., Suzuki S. Isolation and characterization of a third proteoglycan (PG-Lt) from chick embryo cartilage which contains disulfide-bonded collagenous polypeptide. J. Biol. Chem. 1983, 258:9323-9331.
186. Huber S., Winterhalter K.H., Vaughan L. Isolation and sequence-analysis of the glycosaminoglycan attachment site of type-IX collagen. J. Biol. Chem. 1988, 263:752-756.
187. Brewton R.G., Wright D.W., Mayne R. Structural and functional comparison of type IX collagen-proteoglycan from chicken cartilage and vitreous humor. J. Biol. Chem. 1991, 266:4752-4757.
188. Nishimura I., Muragaki Y., Olsen B.R. Tissue-specific forms of type IX collagen-proteoglycan arise from the use of two widely separated promoters. J. Biol. Chem. 1989, 264:20033-20041.
189. Muragaki Y., Nishimura I., Henney A., Ninomiya Y., Olsen B.R. The alpha 1(IX) collagen gene gives rise to two different transcripts in both mouse embryonic and human fetal RNA. Proc. Natl. Acad. Sci. USA 1990, 87:2400-2404.
190. Fassler R., Schnegelsberg P.N., Dausman J., Shinya T., Muragaki Y., McCarthy M.T., Olsen B.R., Jaenisch R. Mice lacking ?1(IX) collagen develop non-inflammatory degenerative joint disease. Proc. Natl. Acad. Sci. USA 1994, 91:5070-5074.
191. Watt S.L., Lunstrum G.P., McDonough A.M., Keene D.R., Burgeson R.E., Morris N.P. Characterization of collagen types XII and XIV from fetal bovine cartilage. J. Biol. Chem. 1992, 267:20093-20099.
192. Gordon M.K., Gerecke D.R., Olsen B.R. Type XII collagen: Distinct extracellular matrix component discovered by cRNA cloning. Proc. Natl. Acad. Sci. USA 1987, 84:6040-6044.
193. Dublet B., van der Rest M. Type XIV collagen, a new homotrimeric molecule extracted from bovine skin and tendon, with a triple helical disulfide-bonded domain homologous to type IX and type XII collagens. J. Biol. Chem. 1991, 266:6853-6858.
194. Lunstrum G.P., Morris N.P., McDonough A.M., Keene D.R., Burgeson R.E. Identification and partial characterization of two type XII-like collagen molecules. J. Cell Biol. 1991, 113:963-969.
195. Keene D.R., Lunstrum G.P., Morris N.P., Stoddard D.W., Burgeson R.E. Two type XII-like collagens localize to the surface of banded collagen fibrils. J. Cell Biol. 1991, 113:971-978.
196. Lunstrum G.P., McDonough A.M., Marinkovich M.P., Keene D.R., Morris N.P., Burgeson R.E. Identification and partial purification of a large, variant form of type XII collagen. J. Biol. Chem. 1992, 267:20087-20092.
197. Gerecke D.R., Olson P.F., Koch M., Knoll J.H., Taylor R., Hudson D.L., Champliaud M.F., Olsen B.R., Burgeson R.E. Complete primary structure of two splice variants of collagen XII, and assignment of alpha I(XII) collagen (COL12A1), alpha I(IX) collagen (COL9A1), and alpha I(XIX) collagen (COL19A1) to human chromosome 6q12-q13. Genomics 1997, 41:236-242.
198. Aubert-Foucher E., Font B., Eichenberger D., Goldschmidt D., Lethias C., van der Rest M. Purification and characterization of native type XIV collagen. J. Biol. Chem. 1992, 267:15759-15764.
199. Schuppan D., Cantaluppi M.C., Becker J., Veit A., Bunte T., Troyer D., Schuppan F., Schmid M., Ackermann R., Hahn E.G. Undulin an extracellular matrix glycoprotein associated with collagen fibrils. J. Biol. Chem. 1990, 265:8823-8832.
200. Walchli C., Koch M., Chiquet M., Odermatt B.F., Trueb B. Tissue-specific expression of the fibril-associated collagens XII and XIV. J. Cell Sci. 1994, 107:669-681.
201. Berthod F., Germain L., Guignard R., Lethias C., Garrone R., Damour O., van der Rest M., Auger F.A. Differential expression of collagens XII and XIV in human skin and in reconstructed skin. J. Invest. Dermatol. 1997, 108:737-742.
202. Font B., Aubert-Foucher E., Goldschmidt D., Eichenberger D., van der Rest M. Binding of collagen XIV with the dematan sulfate side chain of decorin. J. Biol. Chem. 1993, 268:25015-25018.
203. Ehnis T., Dieterich W., Bauer M., Kresse H., Schuppan D. Localization of a binding site for the proteoglycan decorin on collagen XIV (undulin). J. Biol. Chem. 1997, 272:20414-20419.
204. Kassner A., Hansen U., Miosge N., Reinhardt D.P., Aigner T., Bruckner-Tuderman L., Bruckner P., Grassel S. Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded microfibrils. Matrix Biol. 2003, 22:131-143.
205. Kassner A., Tiedemann K., Notbohm H., Ludwig T., Morgelin M., Reinhardt D.P., Chu M.L., Bruckner P., Grassel S. Molecular structure and interaction of recombinant human type XVI collagen. J. Mol. Biol. 2004, 339:835-853.
206. Pan T.C., Zhang R.Z., Mattei M.G., Timpl R., Chu M.L. Cloning and chromosomal location of human alpha I(XVI) collagen. Proc. Natl. Acad. Sci. USA 1992, 89:6565-6569.
207. Myers J.C., Li D., Amenta P.S., Clark C.C., Nagaswami C., Weisel J.W. Type XIX collagen purified from human umbilical cord is characterized by multiple sharp kinks delineating collagenous subdomains and by intermolecular aggregates via globular, disulfide-linked, and heparin-binding amino termini. J. Biol. Chem. 2003, 278:32047-32057.
208. Sumiyoshi H., Inoguchi K., Khaleduzzaman M., Ninomiya Y., Yoshioka H. Ubiquitous expression of the alphaI(XIX) collagen gene (Col19a1) during mouse embryogenesis becomes restricted to a few tissues in the adult organism. J. Biol. Chem. 1997, 272:17104-17111.
209. Tuckwell D. Identification and analysis of collagen alpha I(XXI), a novel member of the FACIT collagen family. Matrix Biol. 2002, 21:63-66.
210. Timpl R., Engel J. Type VI collagen. Structure and Function of Collagen Types 1987, 105-143. Academic Press. R. Mayne, R.E. Burgeson (Eds.).
211. Chu M.L., Pan T.C., Conway D., Kuo H.J., Glanville R.W., Timpl R., Mann K., Deutzmann R. Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus. EMBO J. 1989, 8:1939-1946.
212. Bonaldo P., Russo V., Bucciotti F., Bressan G.M., Colombatti A. Alpha 1 chain of chick type VI collagen. The complete cDNA sequence reveals a hybrid molecule made of one short collagen and three von Willebrand factor type A-like domains. J. Biol. Chem. 1989, 264:5575-5580.
213. Koller E., Winterhalter K.H., Trueb B. The globular domains of type VI collagen are related to the collagen-binding domains of cartilage matrix protein and von Willebrand factor. EMBO J. 1989, 8:1073-1077.
214. Ball S., Bella J., Kielty C., Shuttleworth A. Structural basis of type VI collagen dimer formation. J. Biol. Chem. 2003, 278:15326-15332.
215. Doliana R., Mucignat M.T., Segat D., Zanussi S., Fabbro C., Lakshmi T.R., Colombatti A. Alternative splicing of VWFA modules generates variants of type VI collagen alpha 3 chain with a distinctive expression pattern in embryonic chicken tissues and potentially different adhesive function. Matrix Biol. 1998, 16:427-442.
216. Saitta B., Stokes D.G., Vissing H., Timpl R., Chu M.L. Alternative splicing of the human alpha 2(VI) collagen gene generates multiple mRNA transcripts which predict three protein variants with distinct carbonxyl termini. J. Biol. Chem. 1990, 265:6473-6480.
217. Mayer U., Poschl E., Nischt R., Specks U., Pan T.C., Chu M.L., Timpl R. Recombinant expression and properties of the Kunitz-type protease-inhibitor module from human type VI collagen alpha 3 (VI) chain. Eur. J. Biochem. 1994, 225:573-580.
218. Heckmann M., Aumailley M., Hatamochi A., Chu M.-L., Timpl R., Krieg T. Down-regulation of alpha3(VI) chain expression by gamma-interferon dereases synthesis and deposition of collagen type VI. Eur. J. Biochem. 1989, 182:719-726.
219. Doane K.J., Howell S.J., Birk D.E. Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. Invest. Ophthalml. Vil. Sci. 1998, 39:263-275.
220. Kuo H.J., Maslen C.L., Keene D.R., Glanville R.W. Type VI collagen anchors endothe lial basement membranes by interacting with type IV collagen. J. Biol. Chem. 1997, 272:26522-26529.
221. Furthmayr H., Wiedemann H., Timpl R., Odermatt E., Engel J. Electron-microscopical approach to a structural model of intima collagen. Biochem. J. 1983, 211:303-311.
222. Bruns R.R., Press W., Engvall E.T., Gross J. Type VI collagen in extracellular, 100-nm periodic filaments and fibrils: identification by immunoelectron microscopy. J. Cell Biol. 1986, 103:393-404.
223. von der Mark H, Aumailley M., Wick G., Fleischmajer R., Timpl R. Immunochemistry, genuine size and tissue localization of collagen VI. Eur. J. Biochem. 1984, 142:493-502.
224. Wiberg C., Klatt A.R., Wagener R., Paulsson M., Bateman J.F., Heinegard D., Morgelin M. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 2003, 278:37698-37704.
225. Wiberg C., Heinegard D., Wenglen C., Timpl R., Morgelin M. Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J. Biol. Chem. 2002, 277:49120-49126.
226. Quarto R., Dozin B., Bonaldo P., Cancedda R., Colombatti A. Type VI collagen expression is upregulated in the early events of chondrocyte differentiation. Development 1993, 117:245-251.
227. Swoboda B., Pullig O., Kirsch T., Kladny B., Steinhauser B., Weseloh G. Increased content of type-VI collagen epitopes in human osteoarthritic cartilage: quantitation by inhibition ELISA. J Orthop. Res. 1998, 16:96-99.
228. Kielty C.M., Cummings C., Whittaker S.P., Shuttleworth C.A., Grant M.E. Isolation and ultrastructural analysis of microfibrillar structures from foetal bovine elastic tissues. Relative abundance and supramplecular architecture of type VI collagen assemblies and fibrillin. J. Cell. Sci. 1991, 99:797-807.
229. Aumailley M., Mann K., von der Mark H., Timpl R. Cell attachment properties of collagen type VI and Arg-Gly-Asp dependent binding to its alpha2(VI) and alpha3(VI) chains. Exp. Cell Res. 1989, 181:463-474.
230. Gibson G., Schor S.L., Grant M.E. Effects of matrix molecules on chondrocyte gene expression. Synthesis of a low molecular weight collagen species by cells cultured with collagen gels. J. Cell Biol. 1982, 93:767-774.
231. Capasso O., Tajana G., Cancedda R. Location of 64K collagen producing chondrocytes in developing chick embryo tibiae. Mol. Cell. Biol. 1984, 4:1163-1168.
232. Schmid T.M., Linsenmayer T.F. Type X collagen. Structure and Function of Collagen types 1987, 223-259. Academic Press. R. Mayne, R.E. Burgeson (Eds.).
233. Aigner T., Frischholz S., Dertinger S., Beier F., Girkontaite I., von der Mark K. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias. Histochem. Cell Biol. 1997, 107:435-440.
234. Girkontaite J., Frischholz S., Lammi P., Wagner K., Swoboda B., Aigner T., von der Mark K. Immunolocalization of type X collagen in normal fetal an adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol. 1996, 15:231-238.
235. Walker G.D., Fischer M., Gannon J., Thompson R.C., Oegama T.R. Expression of type X collagen in osteoarthritis. J. Orthopaedic Res. 1995, 13:4-12.
236. Yamaguchi N., Mayne R., Ninomiya Y. The alpha 1 (VIII) collagen gene is homologous to the alpha 1(X) collagen gene and contains a large exon encoding the entire triple helical and carboxyl-terminal non-triple helical domains of the alpha I (VIII) polypeptide. J. Biol. Chem. 1991, 266:4509-4513.
237. Sawada H., Konomi H., Hirosawa K. Characterization of the collagen in the hexagonal lattice of Descemet's membrane: its relation to type VIII collagen. J. Cell Biol. 1990, 110:219-227.
238. Kwan A.P.L., Cummings C.E., Chapman J.A., Grant M.E. Macromolecular organization of chicken type X collagen in vitro. J. Cell Biol. 1991, 114:597-605.
239. Brass A., Kadler K.E., Thomas J.T., Grant M.E., Boot-Handford R.P. The fibrillar collagens, collagen VIII, collagen X and the C1q complement proteins share a similar domain in their C-terminal non-collagenous regions. FEBS Lett 1992, 303:126-128.
240. Marks D.S., Gregory C.A., Wallis G.A., Brass A., Kadler K.E., Boot-Handford R.P. Metaphyseal chondrodysplasia type Schmid mutations are predicted to occur in two distinct three-dimensional clusters within type X collagen NCl domains that retain the ability to trimerize. J. Biol. Chem. 1999, 274:3632-3641.
241. Bonaventure J., Chaminade F., Maroteaux P. Mutations in three subdomains of the carboxy-terminal region of collagen type X account for most of the Schmid metaphyseal dysplasias. Hum. Genet. 1995, 96:58-64.
242. Chan D., Jacenko O. Phenotypic and biochemical consequences of collagen X mutations in mice and human. Matrix Biol. 1998, 17:169-184.
243. Chan D., Weng Y.M., Golub S., Bateman J.F. Type X collagen NC1 mutations produced by site-directed mutagenesis prevent in vitro assembly. Ann. Acad. Sci. N.Y. 1996, 785:231-233.
244. Wallis G.A., Rash B., Sykes B., Bonaventure J., Maroteaux P., Zabel B., Wynne-Davies R., Grant M.E., Boot-Handford R.P. Mutations within the gene encoding the alph 1(X) chain of type X collagen (COLI0A1) cause metaphyseal chondrodysplasia type Schmid but not several other forms of metaphyseal chondrodysplasia. J. Med. Genet. 1996, 33:450-457.
245. Warman M.L., Abbott M., Apte S.S., Hefferon T., McIntosh I., Cohn D.H., Hecht J.T., Olsen B.R., Francomano C.A. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat. Gen. 1993, 5:79-82.
246. Dublet B., Vernet T., van der Rest M. Schmid's metaphyseal chondrodysplasia mutations interfere with folding of the C-terminal domain of human collagen X expressed in Escherichia coli. J. Biol. Chem. 1999, 274:18909-18915.
247. Jacenko O., LuValle P.A., Olsen B.R. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage to bone transition. Nature 1993, 365:56-61.
248. Rosati R., Horan G.S., Pinero G.J., Garofalo S., Keene D.R., Horton W.A., Vuorio E., deCrombrugghe B., Behringer R.R. Normal long bone growth and development in type X collagennull mice. Nat. Gen. 1994, 8:129-135.
249. Gress C.J., Jacenko O. Growth plate compressions and altered hematopoiesis in collagen X null mice. J. Cell. Biol. 2000, 149:983-993.
250. Hagg P.M., Horelli-Kuitunen N., Eklund L., Palotie A., Pihlajaniemi T. Cloning of mouse type XV collagen sequences and mapping of the corresponding gene to 4B1-3., Comparison of mouse and human alpha 1(XV) collagen sequences indicates divergence in the number of small collagenous domains. Genomics 1997, 45:31-41.
251. Rehn M., Hintikka E., Pihlajaniemi T. Characterization of the mouse gene for the alpha 1 chain of type XVIII colagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promotes. Genomics 1996, 32:436-446.
252. Oh S.P., Kamagata Y., Muragaki Y., Timmons S., Ooshima A., Olsen B.R. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:4229-4233.
253. Van den Bergh F., Giudine G.J. BP180 (type XVII collagen) and its role in cutaneous biology and disease. Adv. Dermatol. 2003, 19:37-71.
254. Ricard-Blum S., Dublet B., van der Rest M. Unconventional Collagens Types VI, VII, VIII, IX, X, XIV, XVI and XIX 2000, 155. Oxford University Press. S. Ricard-Blum, B. Dublet, M. van der Rest (Eds.).
255. Tu H., Sasaki T., Snellman A., Gohring W., Pirila P., Timpl R., Pihlajaniemi T. The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin. J. Biol. Chem. 2002, 277:23092-23099.
256. Nykvist P., Tu H., Ivaska J., Kapyla J., Pihlajaniemi T., Heino J. Distinct recognition of collagen subtypes by alpha(I) beta(1) and alpha(2)beta(1) integrins. Alpha(1)beta(1) mediates cell adhesion to type XII collagen. J. Biol. Chem. 2000, 275:8255-8261.
257. Juvonen M., Pihlajaniemi T. Characterization of the spectrum of alternative splicing of alpha 1 (XII) collagen transcripts in HT-1080 cells and calvarial tissue resulted in identification of two previously unidentified alternatively spliced sequences, one previously unidentified exon, and nine new mRNA variants. J. Biol. Chem. 1992, 267:24693-24699.
258. Rehn M., Pihlajaniemi T. Alpha (XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:4234-4238.
259. Rehn M., Hintikka E., Pihlajaniemi T. Primary structure of the alpha 1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the alpha 1 (XVIII) chain with its homologue, the alpha 1(XV) collagen chain. J. Biol. Chem. 1994, 269:13929-13935.
260. Pufe T., Petersen W.J., Miosge N., Goldring M.B., Mentlein R., Varoga D.J., Tillmann B.N. Endostatin/collagen XVIII-an inhibitor of angio genesis-is expressed in cartilage and fibrocartilage. Matrix Biol. 2004, 23:267-276.
261. Sasaki T., Fukai N., Mann K., Gohring W., Olsen B.R., Timpl R. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 1998, 17:4249-4256.
262. Olsen B.R. Collagen Biosynthesis. Cell Biology of Extracellular Matrix 1981, 139-177. Plenum Press, New York. E.D. Hay (Ed.).
263. Ryan M.C., Sieraski M., Sandell L.J. The human type II procollagen gene: identification of an additional protein-coding domain and location of potential regulatory sequences in the promoter and first intron. Genomics 1990, 8:41-48.
264. Peltonen S., Rehn M., Pihlajaniemi T. Alternative splicing of mouse alphal (XIII) collagen RNAs results in at least 17 different transcripts, predicting alphal (XIII) collagen chains with length varying between 651 and 710 amino acid residues. DNA Cell Biol. 1997, 16:227-234.
265. Chu M.L., de Wet W., Bernard M., Ramirez F. Fine structureal analysis of the human pro-alpha 1 (1) collagen gene Promoter structure, Alut repeats, and polymorphic transcripts. J. Biol. Chem. 1985, 260:2315-2320.
266. Focht R.J., Adams S.L. Tissue specificity of type 1 collagen gene expression is determined at both transcriptional and post-transcriptional levels. Mol. Cell. Biol. 1984, 4:1843-1852.
267. Mauch C., Hatamochi A., Scharffetter K., Krieg T. Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp. Cell Res. 1988, 178:493-503.
268. Eckes B., Mauch C., Huppe G., Krieg T. Downregulation of collagen synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and postranscriptional mechanisms. FEBS Lett. 1993, 318:129-133.
269. Kivirikko K.I., Myllyharju J. Proly 14-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 1998, 16:357-368.
270. Kivirikko K.I., Myllyla R. Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes. Methods Enzymol 1982, 82:245-304.
271. Kivirikko K.I., Pihlajaniemi T. Collagen hydroxylases and the protein disulfide isomerase subunit of prolyl 4-hydroxylases. Adv. Enzymol. Relat. Areas Mol. Biol. 1998, 72:325-398.
272. Vranka J.A., Sakai L.Y., Bachinger H.P. Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J. Biol. Chem. 2004, 279:23615-23621.
273. Tryggvason K., Majamaa K., Risteli J., Kivirikko K.I. Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. Biochem. J. 1979, 183:303-307.
274. Helaakoski T., Veijola J., Vuori K., Rehn M., Chow L.T., Taillon-Miller P., Kivirikko K.I., Pihlajaniemi T. Structure and expression of the human gene for the alpha subunit of prolyl 4-hydroxylase. The two alternatively spliced types of mRNA correspond to two homologous exons the sequences of which are expressed in a variety of tissues. J. Biol. Chem. 1994, 269:27847-27854.
275. Annunen P., Hellaakoski T., Myllyharju J., Veijola J., Pihlajaniemi T., Kivirikko K.I. Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer. The alpha(I) and alpha(II) subunits do not form a mixed alpha(I)alpha(II)beta2 tetramer. J. Biol. Chem. 1997, 272:17342-17348.
276. Chvapil M., Ryan J.N. Diverse effect of 1,10-phenanthroline and 2,2'-dipyridyl on the synthesis of collagen and noncollagenous proteins in in vivo and in vitro systems. Biochim. Biophys. Acta 1972, 273:208-211.
277. Bienkowski R.S. Intracellular degradation of newly synthe-sized collagne. Revis. Biol. Celular 1989, 21:423-443.
278. Hanauske-Abel H.M. Proly 14-hydroxylase, a target enzyme for drug development. Design of suppressive agents and the in vitro effects of inhibitors and proinhibitors. J. Hepatol. 1991, 13(Suppl 3):S8-S15. discussion S16.
279. Tschank G., Brocks D.G., Engelbart K., Mohr J., Baader E., Gunzler V., Hanauske-Abel H.M. Inhibition of prolyl hydroxylation and procollagen processing in chick embryo calvaria by a derivative of pyridine-2,4- dicarboxylate. Characterization of the diethyl ester as a proinhibitor. Biochem. J. 1991, 275:469-476.
280. Myllyla R., Pihlajaniemi T., Pajaunen L., Turpeenniemi-Hujanen T., Kivirikko K.I. Molecular cloning of chick lysyl hydroxylase. Little homology in primary structure to the two types of subunit of prolyl 4-hydroxylase. J. Biol. Chem. 1991, 266:2805-2810.
281. Rautavuoma K.I., Takaluoma K., Passoja K., Pirskanen A., Kvist A.P., Kivirikko K.I., Myllyharju J. Characterization of three fragments that constitute the monomens of the human lysyl hydroxylase isoenzymes 1-3. The 30-kDa N-terminal fragment is not required for lysyl hydroxylase activity. J. Biol. Chem. 2002, 277:23084-23091.
282. Smith-Mungo L.I., Kagan H.M. Lysyl oxidase: properties regulation and multiple functions in biology. Matrix Biol. 1998, 16:387-398.
283. Knott L., Bailey A.J. Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 1998, 22:181-187.
284. Blumenkrantz N., Assad R., Peterkofsky B. Characterization of collagen hydroxylysyl glycosyltransferases as mainly intramembraneous microsomal enzymes. J. Biol. Chem. 1984, 259:854-859.
285. Clark C.C. The distribution and initial characterization of oligosaccharide units on the COOH-terminal propeptide extensions of the pro-alpha 1 and pro-alpha 2 chains of type 1 procollagen. J. Biol. Chem. 1979, 254:10798-10802.
286. Doege K.J., Fessler J.H. Folding of carboxyl domain and assembly of procollagen I. J. Biol. Chem. 1986, 261:8924-8935.
287. Freedman R.B., Hirst T.R., Tuite M.F. Protein disulphide isomerase: building bridges in protein folding. Trends. Biochem. Sci. 1994, 19:331-336.
288. Lang K., Schmid F.X., Fischer G. Catalysis of protein folding by prolyl isomerase. Nature 1987, 329:268-270.
289. Bulleid N.J., Dalley J.A., Lees J.F. The C-propeptide domain of procollagen can be replaced with a transmembrane domain without affecting trimer formation or collagen triple helix folding during biosynthesis. EMBO J. 1997, 16:6694-6701.
290. Steinmann B., Bruckner P., Superti-Furga A. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J. Biol. Chem. 1991, 266:1299-1303.
291. Nakai A., Satoh M., Hirayoshi K., Nagata K. Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J. Cell Biol. 1992, 117:903-914.
292. Nagata K., Hosokawa N. Regulation and function of collagen-specific molecular chaperone, HSP47. Cell Struct. Funct. 1996, 21:425-430.
293. Nagata K. Hsp47: a collagen-specific molecular chaperone. Trends. Biochem. Sci. 1996, 21:22-26.
294. Natsume T., Koide T., Yokota S., Hirayoshi K., Nagata K. Interactions between collagen-binding stress protein HSP47 and collagen. Analysis of kinetic parameters by surface plasmon resonance biosensor. J. Biol. Chem. 1994, 269:31224-31228.
295. Hattori T., Von Der Mark K., Kawaki H., Yutani Y., Kubota S., Nakanishi T., Eberspaecher H., De Crombrugghe B., Takigawa M. Downregulation of rheumatoid arthritis-related antigen RA-A47 (HSP47/colligin-2) in chondrocytic cell lines induces apoptosis and cell-surface expression of RA-A47 in association with CD9. J. Cell Physiol. 2004, 30:30.
296. Rawlings N.D., Barrett A.J. Evolutionary families of metallopeptidases. Methods Enzymol. 1995, 248:183-228.
297. Hojima Y., McKenzie J.A., van der Rest M., Prockop D.J. Type I procollagen N-proteinase from chick embryo tendons. Purification of a new 500-kDa form of the enzyme and identification of the catlytically active polypeptides. J. Biol. Chem. 1989, 264:11336-11345.
298. Colige A., Li S.W., Sieron A.L., Nusgens B.V., Prockop D.J., Lapiere C.M. cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinemetalloproteinases with binding sites for cells and other matrix components. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:2374-2379.
299. Tuderman L., Prockop D.J. Procollagen N-proteinase Properties of the enzyme purified from chick embryo tendons. Eur. J. Biochem. 1982, 125:545-549.
300. Li S.W., Sieron A.L., Fertala A., Hojima Y., Amold W.V., Prockop D.J. The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5127-5130.
301. Suzuki N., Labosky P.A., Furuta Y., Hargett L., Dunn R., Fogo A.B., Takahara K., Peters D.M., Greenspan D.S., Hogan B.L. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmpl, a mammalian gene related to Drosophila tolloid. Development 1996, 122:3587-3595.
302. Helseth D.L., Veis A. Cathepsin D-mediated processing of procollagen: lysosomal enzyme involvement in secretory processing of procollagen. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:3302-3306.
303. Hamalainen E.R., Kemppainen R., Pihlajaniemi T., Kivirikko K.I. Structure of the human lysyl oxidase gene. Genomics 1993, 17:544-548.
304. Ramirez F., diLiberto M. Complex and diversified regulatory programs control the expression of vertebrate collagen genes. FASEB J 1990, 4:1616-1623.
305. Finer M.H., Gerstenfeld L.C., Young D., Doty P., Boedtker H. Collagen expression in embryonic chicken chondrocytes treated with phorbol myristate acetate. Mol. Cell Biol. 1985, 5:1415-1424.
306. Bennett V.D., Adams S.L. Characterization of the translational control mechanism preventing synthesis of alpha 2(I) collagen in chicken vertebral chondroblasts. J. Biol. Chem. 1987, 262:14806-14814.
307. Bennett V.D., Adams S.L. Identification of a cartilagespecific promoter within intron-2 of the chick alpha-2(i) collagen gene. J. Biol. Chem. 1990, 265:2223-2230.
308. Penttinen R.P., Kobayashi S., Bornstein P. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:1105-1108.
309. Speth C., Oberbaumer I. Expression of basement membrane proteins: evidence for complex post-transcriptional control mechanisms. Exp. Cell Res. 1993, 204:302-310.
310. Rossi P., de Crombrugghe B. Formation of a type I collagen RNA dimer by intermolecular base-pairing of a conserved sequence around the translation initiation site. Nucleic Acids Res. 1987, 15:8935-8956.
311. Bornstein P., McKay J., Devarayalu S., Cook S.C. A highly conserved. 5? untranslated, inverted repeat sequence is ineffective in translational control of the alpha 1(I) collagen gene [published erratum appears in Nucleic Acids Res 1988 Dec 9; 16(23);11399]. Nucleic. Acids. Res. 1988, 16:9721-9736.
312. Paglia L., Wilczek J., de Leon L.D., Martin G.R., Horlein D., Muller P. Inhibition of procollagen cell-free synthesis by amino-terminal extension peptides. Biochemistry 1979, 18:5030-5034.
313. Paglia L.M., Wiestner M., Duchene M., Ouellette L.A., Horlein D., Martin G.R., Muller P.K. Effects of procollagen peptides on the translation of type II collagen messenger ribonucleic acid and on collagen biosynthesis in chondrocytes. Biochemistry 1981, 20:3523-3527.
314. Horlein D., McPherson J., Goh S.H., Bornstein P. Regulation of protein synthesis: translational control by procollagen-derived fragments. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:6163-6167.
315. Schlumberger W., Thie M., Volmer H., Rauterberg J., Robenek H. Binding and uptake of Col 1(I), a peptide capable of inhibiting collagen synthesis in fibroblasts. Eur. J. Cell Biol. 1988, 46:244-252.
316. Fouser L., Sage E.H., Clark J., Bornstein P. Feedback regulation of collagen gene expression: a Trojan horse approach. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10158-10162.
317. Wu C.H., Donovan C.B., Wu G.Y. Evidence for pretranslational regulation of collagen synthesis by procollagen propertides. J. Biol. Chem. 1986, 261:10482-10484.
318. Aycock R.S., Raghow R., Stricklin G.P., Seyer J.M., Kang A.H. Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxy 1-terminal propeptide of human type I collagne. J. Biol. Chem. 1986, 261:14355-14360.
319. Mizuno M., Fujisawa R., Kuboki Y. The effect of carboxyl-terminal propeptide of type I collagen (c-propeptide) on collagen synthesis of preosteoblasts and osteoblasts. Calcif. Tissue Int. 2000, 67:391-399.
320. Nakata K., Miyamoto S., Bernier S., Tanaka M., Utani A., Krebsbach P., Rhodes C., Yamada Y. The c-propeptide of type II procollagen binds to the enhancer region of the type II procollagen gene and regulates its transcription. Ann. Acad. Sci. N.Y. 1996, 785:307-308.
321. Rossert J.A., Garrett L.A. Regulation of type I collagen synthesis. Kidney Int. Suppl. 1995, 49:S34-S38.
322. Bornstein P. Regulation of expression of the alpha 1 (I) collagen gene: a critical appraisal of the role of the first intron. Matrix Biol. 1996, 15:3-10.
323. Frischauf A.M., Lehrach H., Rosner C., Boedtker H. Procollagen complementary DNA, a probe for messenger RNA purification and the number of type I collagen genes. Biochemistry 1978, 17:3243-3249.
324. Boedtker H., Frischauf A.M., Lehrach H. Isolation and translation of calvaria procollagen messenger ribonucleic acids. Biochemistry 1976, 15:4765-4770.
325. Yamamoto T., Sobel M.E., Adams S.L., Avvedimento V.E., DiLauro R., Pastan I., de Crombrugghe B., Showalter A., Pesciotta D., Fietzek P., Olsen B. Construction of a recombinant bacterial plasmid containing pro-alpha 1(I) collagen DNA sequences. J. Biol. Chem. 1980, 255:2612-2615.
326. Vuorio E., de Crombrugghe B. The family of collagen genes. Annu. Rev. Biochem. 1990, 59:837-872.
327. Chu M.L., de Wet W., Bernard M., Ding J.F., Morabito M., Myers J., Williams C., Ramirez F. Human pro alpha 1(I) collagen gene structure
328. Dewet W., Bernard M., Bensochanda V., Chu M.L., Dickson L., Weil D., Ramirez F. Organization of the human pro-alpha 2(I) collagen gene. J. Biol. Chem. 1987, 262:16032-16036.
329. Chuang P.T., McMahon A.P. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 1999, 397:617-621.
330. Sokolov B.P., Mays P.K., Khillan J.S., Prockop D.J. Tissue- and development-specific expression in transgenic mice of a type 1 procollagen (COL1A1) minigene construct with 2,3 kb of the promoter region and 2 kb of the 3?-flanking region. Specificity is independent of the putative regulatory sequences in the first intron. Biochemistry 1993, 32:9242-9249.
331. Sokolov B.P., Ala-Kokko L., Dhulipala R., Arita M., Khillan J.S., Prockop D.J. Tissue-specific expression of the gene for type I procollagen (COL1A1) in transgenic mice. Only 476 base pairs of the promoter are required if collagen genes are used as reprrters. J. Biol. Chem. 1995, 270:9622-9629.
332. Rossert J.A., Chen S.S., Eberspaecher H., Smith C.N., de Crombrugghe B. Identification of a minimal sequence of the mouse pro-alpha 1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1027-1031.
333. Rossert J., Eberspaecher H., de Crombrugghe B. Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J. Cell Biol. 1995, 129:1421-1432.
334. Bornstein P., McKay J. The first intron of the alpha 1(I) collagen gene contains several transcriptional regulatory elements. J. Biol. Chem. 1988, 263:1603-1606.
335. Slack J.L., Liska D.J., Bornstein P. An upstream regulatory region mediates high-level, tissue-specific expression of the human alpha 1(I) collagen gene in transgenic mice. Mol. Cell Biol. 1991, 11:2066-2074.
336. Liska D.J., Robinson V.R., Bornstein P. Elements in the first intron of the alpha 1(I) collagen gene interact with Sp1 to regulate gene expression. Gene Expr. 1992, 2:379-389.
337. Kern B., Shen J., Starbuck M., Karsenty G. Cbfal contributes to the osteoblast-specific expression of type I collagen genes. J. Biol. Chem. 2001, 276:7101-7107.
338. Pavlin D., Bedalov A., Kronenberg M.S., Kream B.E., Rowe D.W., Smith C.L., Pike J.W., Lichtler A.C. Analysis of regulatory regions in the COL1A1 gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression in osteoblastic cells. J. Cell. Biochem. 1994, 56:490-501.
339. Meisler N., Keefer K.A., Ehrlich H.P., Yager D.R., Myers-Parrelli J., Cutroneo K.R. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J. Invest. Dermatol. 1997, 108:285-289.
340. Meisler N., Shull S., Xie R., Long G.L., Absher M., Connolly J.P., Cutroneo K.R. Glucocorticoids coordinately regulate type 1 collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes. J. Cell. Biochem. 1995, 59:376-388.
341. Rossi P., deCrombrugghe B. Identification of a cell-specific transcriptional enhancer in the first intron of the mouse alpha 2 (type I) collagen gene. Proc. Natl. Acad. Sci. USA 1987, 84:5590-5594.
342. Ignotz R.A., Endo T., Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J. Biol. Chem. 1987, 262:6443-6446.
343. Ritzenthaler J.D., Goldstein R.H., Fine A., Smith B.D. Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. J. Biol. Chem. 1993, 268:13625-13631.
344. D'Souza R.N., Niederreither K., de Crombrugghe B. Osteoblast-specific expression of the alpha 2(1) collagen promoter in transgenic mice: correlation with the distribution of TGF-beta 1. J. Bone Miner. Res. 1993, 8:1127-1136.
345. Chung K.Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(1) collagen (COL1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 1996, 271:3272-3278.
346. Greenwel P., Inagaki Y., Hu W., Walsh M., Ramirez F. Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-betal. J. Biol. Chem. 1997, 272:19738-19745.
347. Higashi K., Kouba D.J., Song Y.J., Uitto J., Mauviel A. A proximal element within the human alpha 2(I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-alpha response element, mediates transcriptional repression by interferon-gamma. Matrix Biol. 1998, 16:447-456.
348. Bou-Gharios G., Garrett L.A., Rossert J., Niederreither K., Eberspaecher H., Smith C., Black C., Crombrugghe B. A potent far-upstream enhancer in the mouse pro alpha 2(1) collagen gene regulates expression of reporter genes in transgemic mice. J. Cell Biol. 1996, 134:1333-1344.
349. Horton W., Miyashita T., Kohno K., Hassell J.R., Yamada Y. Identification of a phenotype-specific enhancer in the first intron of the rat collagen II gene. Proc. Natl. Acad. Sci. USA 1987, 84:8864-8868.
350. Zhou G., Garofalo S., Mukhopadhyay K., Lefebvre V., Smith C.N., Eberspaecher H., de Crombrugghe B. A 182 bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J. Cell Sci. 1995, 108:3677-3684.
351. Mukhopadhyay K., Lefebvre V., Zhou G., Garofalo S., Kimura J.H., de Crombrugghe B. Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse proalpha I(II) collagen gene. J. Biol. Chem. 1995, 270:27711-27719.
352. Zhou G., Lefebvre V., Zhang Z., Eberspaecher H., de Crombrugghe B. Three high mobility group-like sequences within a 48-base pair enhancer of the Co12a1 gene are required for cartilage-specific expression in vivo. J. Biol. Chem. 1998, 273:14989-14997.
353. Lefebvre V., Zhou G., Mukhopadhyay K., Smith C.N., Zhang Z., Eberspaecher H., Zhou X., Sinha S., Maity S.N., de Crombrugghe B. An 18-base-pair sequence in the mouse proalpha 1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol. Cell Biol. 1996, 16:4512-4523.
354. Lefebvre V., de Crombrugghe B. Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol. 1998, 16:529-540.
355. Savagner P., Krebsbach P.H., Hatano O., Miyashita T., Liebman J., Yamada Y. Collagen II promoter and enhancer interact synergistically through Sp1 and distinct nuclear factors. DNA Cell Biol. 1995, 14:501-510.
356. Ruteshouser E.C., de Crombrugghe B. Purification of BBF, a DNA-binding protein recognizing a positive cis-acting element in the mouse alpha 1(III) collagen promoter. J. Biol. Chem. 1992, 267:14398-14404.
357. Mudryj M., de Crombrugghe B. Deletion analysis of the mouse alpha 1(III) collagen promoter. Nucleic. Acids. Res. 1988, 16:7513-7526.
358. Takahara K., Hoffman G.G., Greenspan D.S. Complete structural organization of the human alpha 1 (V) collagen gene (COL5A1): divergence from the conserved organization of other characterized fibrillar collagen genes. Genomics 1995, 29:588-597.
359. Lee S., Greenspan D.S. Transcriptional promoter of the human alpha 1(V) collagen gene (COL5A1). Biochem. J. 1995, 310:15-22.
360. Truter S., Di Liberto M., Inagaki Y., Ramirez F. Identification of an upstream regulatory region essential for cell typespecific transcription of the pro-alpha 2(V) collagen gene (COL5A2). J. Biol. Chem. 1992, 267:25389-25395.
361. Nagato H., Matsuo N., Sumiyoshi H., Sakata-Takatani K., Nasu M., Yoshioka H. The transcription factor CCAAT-binding-factor CBF/NF-Y and two repressors regulate the core promoter of the human Proa 3(V) collagen gene(COL5A3). J. Biol. Chem. 2004, 279. in press.
362. Yoshioka H., Greenwel P., Inoguchi K., Truter S., Inagaki Y., Ninomiya Y., Ramirez F. Structural and functional analysis of the promoter of the human alpha 1(XI) collagen gene. J. Biol. Chem. 1995, 270:418-424.
363. Yoshioka H., Inoguchi K., Khaleduzzaman M., Ninomiya Y., Andrikopoulos K., Ramirez F. Coding sequence and alternative, splicing of the mouse alpha 1(XI) collagen gene (Coll 1a1). Genomics 1995, 28:337-340.
364. Lui V.C., Ng L.J., Sat E.W., Cheah K.S. The human alpha 2(XI) collagen gene (COL11A2): completion of coding information, identification of the promoter sequence, and precise localization within the major histocompatibility complex reveal overlap with the KE5 gene. Genomics 1996, 32:401-412.
365. Bridgewater L.C., Lefebvre V., de Crombrugghe B. Chondrocyte-specific enhancer elements in the Coll 1a2 gene resemble the Co12a1 tissue-specific enhancer. J. Biol. Chem. 1998, 273:14998-15006.
366. Hayman A.R., Koppel J., Trueb B. Complete structure of the chicken alpha 2(VI) collagen gene. Eur. J. Biochem. 1991, 197:177-184.
367. Trikka D., Davis T., Lapenta V., Brahe C., Kessling A.M. Human COL6A1: genomic characterization of the globular domains, structural and evolutionary comparison with COL6A2. Mamum. Genome. 1997, 8:342-345.
368. Walchli C., Marcionelli R., Odermatt B.F., Peltonen J., Vuorio E., Trueb B. Expression and distribution of two alternatively spliced transcripts from the chicken alpha 2 (VI) collagen gene. J. Cell Biochem. 1996, 63:207-220.
369. Doliana R., Bonaldo P., Colombatti A. Multiple forms of chicken alpha 3(VI) collagen chain generated by alternative splicing in type A repeated domains. J. Cell Biol. 1990, 111:2197-2205.
370. Braghetta P., Fabbro C., Piccolo S., Marvulli D., Bonaldo P., Volpin D., Bressan G.M. Distinct regions control transcriptional activation of the alpha 1(VI) collagen promoter in different tissues of transgenic mice. J. Cell Biol. 1996, 135:1163-1177.
371. Piccolo S., Bonaldo P., Vitale P., Volpin D., Bressan G.M. Transcriptional activation of the alpha 1(VI) collagen gene during myoblast differentiation is mediated by multiple GA boxes. J. Biol. Chem. 1995, 270:19583-19590.
372. Fabbro C., Braghetta P., Girotto D., Piccolo S., Volpin D., Bressan G.M. Cell type-specific transcription of the alpha 1(VI) collagen gene. Role of the apl binding site and of the core promoter. J. Biol. Chem. 1999, 274:1759-1766.
373. Saitta B., Chu M.L. Characterization of the human alpha 1(VI) collagen promoter and its comparison with human alpha 2(VI) promoters. Eur. J. Biochem. 1995, 234:542-549.
374. Braghetta P., Vitale P., Piccolo S., Bonaldo P., Fabbro C., Girotto D., Volpin D., Bressan G.M. Tissue-specific expression of promoter regions of the alpha 1(VI) collagen gene in cell cultures and transgenic mice. Eur. J. Biochem. 1997, 247:200-208.
375. Willimann T.E., Maier R., Trueb B. A novel transcription factor and two members of the Sp1 multigene family regulate the activity of the alpha 2(VI) collagen promoter. Matrix Biol. 1995, 14:653-663.
376. Hatamochi A., Aumailley M., Mauch C., Chu M.-L., Timpl R., Krieg T. Regulation of collagen VI expression in fibroblasts. Effects of cell density, cell-matrix interactions, and chemical transformation. J. Biol. Chem. 1989, 264:3494-3499.
377. Peltonen J., Hsiao L.L., Jaakkola S., Sollberg S., Aumailley M., Timpl R., Chu M.L., Uitto J. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J. Invest. Dermatol. 1991, 97:240-248.
378. Harumiya S., Gibson M.A., Koshihara Y. Antisense suppression of collagen VI synthesis results in reduced expression of collagen 1 in normal human osteoblast-like cells. Biosci. Biotechnol. Biochem. 2002, 66:2743-2747.
379. Heckmann M., Aumailley M., Chu M.L., Timpl R., Krieg T. Effect of transforming growth factor-beta on collagen type VI expression in human dermal fibroblasts. FEBS Lett. 1992, 310:79-82.
380. Luvalle P., Ninomiya Y., Rosenblum N.D. The type X collagen gene. J. Biol. Chem. 1988, 263:18378-18385.
381. Elima K., Eerola I., Rosati R., Metsäranta M., Garofalo S., Perälä M., deCrombrugghe B., Vuorio E. The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem. J. 1993, 289:247-253.
382. Kong R.Y., Kwan K.M., Lau E.T., Thomas J.T., Boot-Handford R.P., Grant M.E., Cheah K.S. Intron-exon structure, alternative use of promoter and expression of the mouse collagen X gene, COL10A-1. Eur. J. Biochem. 1993, 213:99-111.
383. Apte S.S., Olsen B.R. Characterization of the mouse type X collagen gene. Matrix 1993, 13:165-179.
384. Thomas J.T., Kwan A.P.L., Grant M.E., Boot-Handford R.P. Isolation of cDNAs encoding the complete sequence of bovine type X collagen. Biochem. J. 1991, 273:141-148.
385. Thomas J.T., Cresswell C.J., Rash B., Nicolai H., Jones T., Solomon E., Grant M.E., Boot-Handford R.P. The human collagen X gene. Biochem. J. 1991, 280:617-623.
386. Reichenberger E., Beier F., Luvalle P., Olsen B.R., von der Mark K., Bertling W. Genomic organisation and full length cDNA sequence of human collagen X. FEBS Lett. 1992, 311:305-310.
387. Beier F., Eerola I., Vuorio E., Luvalle P., Reichenberger E., Bertling W., von der Mark K., Lammi M.J. Variability in the upstream promoter and intron sequences of the human, mouse and chick type X collagen genes. Matrix Biol. 1996, 15:415-422.
388. Luvalle P., Daniels K., Hay E.D., Olsen B. Type X collagen is transcriptionally activated and specifically localized during sternal cartilage maturation. Matrix 1992, 12:404-413.
389. Schmid I.M., Linsenmayer T.F. Immunohistochemical localization of short chain cartilage collagen (type-X) in avian tissues. J. Cell Biol. 1985, 100:598-605.
390. Reichenberger E., Aigner T., von der Mark K., Stoess H., Bertling W. In situ hybridization studies on the expression of type X collagen in fetal human cartilage. Develop. Biol. 1991, 148:562-572.
391. Luvalle P., Iwamoto M., Fanning P., Pacifici M., Olsen B.R. Multiple negative elements in a gene that codes for an extracellular matrix protein, collagen X, restrict expression to hypertrophic chondrocytes. J. Cell Biol. 1993, 121:1173-1179.
392. Dourado G., Luvalle P. Proximal DNA elements mediate repressor activity conferred by the distal portion of the chicken collagen X promoter. J. Cell Biochem. 1998, 70:507-516.
393. Long F., Somenshein G.E., Linsenmayer T.F. Multiple transcriptional elements in the avian type X collagen gene. Identification of Sp1 family proteins as regulators for high level expression in hypertrophic chondrocytes. J. Biol. Chem. 1998, 273:6542-6549.
394. Volk S.W., Luvalle P., Leask T., Leboy P.S. A BMP responsive transcriptional region in the chicken type X collagen gene. J. Bone. Miner. Res. 1998, 13:1521-1529.
395. Beier F., Vornehm S., Pöschl E., von der Mark K., Lammi M.J. Localization of silencer and enhancer elements in the human type X collagen gene. J. Cell Biochem. 1997, 66:210-218.
396. Chambers D., Young D.A., Howard C., Thomas J.T., Boam D.S., Grant M.E., Wallis G.A., Boot-Handford R.P. An enhancer complex confers both high-level and cell-specific expression of the human type X collagen gene. FEBS Lett. 2002, 531:505-508.
397. Riemer S., Gebhard S., Beier F., Poschl E., von der Mark K. Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: localization of a PTH/PTHrP-responsive region in the human COL10A1 enhancer. J. Cell Biochem. 2002, 86:688-699.
398. Gebhard S., Poschl E., Riemer S., Bauer E., Hattori T., Eberspaecher H., Zhang Z., Lefebvre V., de Crombrugghe B., von der Mark K. A highly conserved enhancer in mammalian type X collagen genes drives high levels of tissue-specific expression in hypertrophic cartilage in vitro and in vivo. Matrix Biol. 2004, 23:309-322.
399. O'Keefe R.J., Loveys L.S., Hicks D.G., Reynolds P.R., Crabb I.D., Puzas J.E., Rosier R.N. Differential regulation of type-II and type-X collagen synthesis by parathyroid hormone-related protein in chick growth-plate chondrocytes. J. Orthop. Res. 1997, 15:162-174.
400. Harada S., Sampath T.K., Rodan G.A. Identification of an AP1-like response region for osteogenic protein-1 in type X collagen promoter. Ann. Acad. Sci. N.Y. 1996, 785:259-260.
401. Zheng Q., Zhou G., Morello R., Chen Y., Garcia-Rojas X., Lee B. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol. 2003, 162:833-842.
402. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
403. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89:765-771.
404. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
405. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
406. Slavin J., Unemori E., Hunt T.K., Amento E. Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. Growth Factors 1994, 11:205-213.
407. Murata H., Zhou L., Ochoa S., Hasan A., Badiavas E., Falanga V. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J. Invest. Dermatol. 1997, 108:258-262.
408. Inagaki Y., Truter S., Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J. Biol. Chem. 1994, 269:14828-14834.
409. Inagaki Y., Nemoto T., Nakao A., Dijke P., Kobayashi K., Takehara K., Greenwel P. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J. Biol. Chem. 2001, 276:16573-16579.
410. Chen S.J., Yuan W., Lo S., Trojanowska M., Varga J. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. J. Cell Physiol. 2000, 183:381-392.
411. Wang E.A., Rosen V., D'Alessando J., Bauduy M., Cordes P., Harada T., Israk D.I., Hewick R.M., Kern K.M., LaDan P., Luxenberg D.P., McQuaid D., Mountsatsos J.K., Nove J., Wozney J.M. Recombinant human bone morphogenetic protein induces bone formation. PNAS 1990, 87:2220-2224.
412. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., White K.H., Coughlin J.E., Tucker M.M., Pang R.H. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 1992, 267:20352-20362.
413. Reddi A.H. Initiation of fracture repair by bone morphogenetic proteins. Clin. Orthop. 1998, S66-S72.
414. Fujii M., Takeda K., Imamura T., Aoki H., Sampath T.K., Enomoto S., Kawabata M., Kato M., Ichijo H., Miyazono K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 1999, 10:3801-3813.
415. Takagi M., Kamiya N., Takahashi T., Ito S., Hasegawa M., Suzuki N., Nakanishi K. Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells. J. Mol. Histol. 2004, 35:81-90.
416. Lepisto J., Peltonen J., Vaha-Kreula M., Soderstrom K., Niinikoski J., Laato M. Selective modulation of collagen gene expression by different isoforms of platelet-derived growth factor in experimental wound healing. Cell Tissue Res. 1996, 286:449-455.
417. Hata R., Sunada H., Arai K., Sato T., Ninomiya Y., Nagai Y., Senoo H. Regulation of collagen metabolism and cell growth by epidermal growth factor and ascorbate in cultured human skin fibroblasts [published erratum appears in Eur J Biochem 1988 Aug 15;175(3): 679]. Eur. J. Biochem. 1988, 173:261-267.
418. Rowe D.W., Kream B.E. Regulation of collagen synthesis in fetal rat calvarian by 1,25-dihydroxy vitamin D3. J. Biol. Chem. 1982, 257:8009-8015.
419. Kuroki Y., Shiozawa S., Kano J., Chihara K. Competition between c-fos and 1,25(OH)2 vitamin D3 in the transcriptional control of type 1 collagen synthesis in MC3T3-E1 osteoblastic cells. J. Cell Physiol. 1995, 164:459-464.
420. Kream B.E., Lafrancis D., Petersen D.N., Woody C., Clark S., Rowe D.W., Lichtler A. Parathyroid hormone represses alpha 1(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice. Mol. Endocrinol. 1993, 7:399-408.
421. Russell S.B., Trupin J.S., Myers J.C., Broquist A.H., Smith J.C., Myles M.E., Russell J.D. Differential glucocorticoid regulation of collagen mRNAs in human dermal fibroblasts. Keloid-derived and fetal fibroblasts are refractory to down-regulation. J. Biol. Chem. 1989, 264:13730-13735.
422. Oikarinen A., Autio P., Vuori J., Vaananen K., Risteli L., Kiistala U., Risteli J. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type 1 procollagen and aminoterminal propeptide of type III procollagen. Br. J. Dermatol. 1992, 126:172-178.
423. Silbermann M.M.M. Dexamethasone impairs growth and collagen synthesis in condylar cartilage in vitro. Bone and Mineral 1987, 2:87-106.
424. Advani S., Lafrancis D., Boglanovic E., Taxel P., Raisz L.G., Kream B.E. Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal mice. Bone 1997, 20:41-46.
425. Kream B.E., Tetradis S., Lafrancis D., Fall P.M., Feyen J.H., Raisz L.G. Modulation of the effects of glucocorticoids on collagen synthesis in fetal rat calvariae by insulin-like growth factor binding protein-2. J. Bone Miner. Res. 1997, 12:889-895.
426. Bird J.L., Tyler J.A. Dexamethasone potentiates the stimulatory effect of insulin-like growth factor-1 on collagen production in cultured human fibroblasts. J. Endocrinol. 1994, 142:571-579.
427. Ireland D.C., Bord S., Beavan S.R., Compston J.E. Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation. J. Cell Biochem. 2002, 86:251-257.
428. Simeone A., Acampora D., Pannese M., D'Esposito M., Stornaiuolo A., Gulisano M., Mallamaci A., Kastury K., Druck T., Huebner K. Cloning and characterization of two members of the vertebrate D1x gene family. Proc. Natl. Acad. Sci. USA 1994, 91:2250-2254.
429. Tadic T., Dodig M., Erceg I., Marijanovic I., Mina M., Kalajzic Z., Velonis D., Kronenberg M.S., Kosher R.A., Ferrari D., Lichtler A.C. Overexpression of Dlx5 in chicken calvarial cells accelerates osteoblastic differentiation. J. Bone Miner. Res. 2002, 17:1008-1014.
430. Ducy P. Cb fal: a molecular switch in osteoblast biology. Dev. Dyn. 2000, 219:461-471.
431. Karsenty G., Ducy P., Starbuck M., Priemel M., Shen J., Geoffroy V., Amling M. Cbfal as a regulator of osteoblast differentiation and function. Bone 1999, 25:107-108.
432. Komori T. A fundamental transcription factor for bone and cartilage. Biochem. Biophys. Res. Commun. 2000, 276:813-816.
433. Kim I.S., Otto F., Zabel B., Mundlos S. Regulation of chondrocyte differentiation by Cbfal. Mech. Dev. 1999, 80:159-170.
434. Thunyakitpisal P., Alvarez M., Tokumaga K., Onyia J.E., Hock J., Ohashi N., Feister H., Rhodes S.J., Bidwell J.P. Cloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type 1 collagen expression in osteoblasts. J. Bone Miner. Res. 2001, 16:10-23.
435. Wagner E.F. Functions of AP1 (Fos/Jun) in bone development. Ann. Rheum. Dis. 2002, 61:ii40-ii42.
436. Grigoriadis A.E., Wang Z.Q., Wagner E.F. Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet. 1995, 11:436-441.
437. Kuroki Y., Shiozawa S., Sugimoto T., Fujita T. Constitutive expression of c-fos gene inhibits type 1 collagen synthesis in transfected osteoblasts. Biochem. Biophys. Res. Commun. 1992, 182:1389-1394.
438. Jinnin M., Ihn H., Yamane K., Tamaki K. Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts. J. Biol. Chem. 2004, 279:41783-41791.
439. Inagaki Y., Nemoto T., Kushida M., Sheng Y., Higashi K., Ikeda K., Kawada N., Shirasaki F., Takehara K., Sugiyama K., Fujii M., Yamauchi H., Nakao A., de Crombrugghe B., Watanabe T., Okazaki I. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 2003, 38:890-899.
440. Rosenbloom J., Feldman G., Freundlich B., Jimenez S.A. Inhibition of excessive scleroderma fibroblast collagen production by recombinant gammainterferon. Association with a coordinate decrease in types 1 and III procollagen messenger RNA levels. Arthritis Rheum. 1986, 29:851-856.
441. Scharffetter K., Heckmann M., Hatamochi A., Mauch C., Stein B., Riethmuller G., Ziegler-Heitbrock H.W., Krieg T. Synergistic effect of tumor necrosis factor-alpha and interferongamma on collagen synthesis of human skin fibroblasts in vitro. Exp. Cell Res. 1989, 181:409-419.
442. Kahari V.M., Chen Y.Q., Su M.W., Ramirez F., Uitto J. Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type 1 collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J. Clin. Invest. 1990, 86:1489-1495.
443. Bird J.L., Tyler J.A. Tumour necrosis factor alpha, interferon gamma and dexamethasone regulate IGF-I-maintained collagen production in cultured human fibroblasts. J. Endocrinol. 1995, 147:167-176.
444. Xu Y., Wang L., Buttice G., Sengupta P.K., Smith B.D. Interferon gamma repression of collagen (COLIA2) transcription is mediated by the RFX5 complex. J. Biol. Chem. 2003, 278:49134-49144.
445. Sengupta P.K., Fargo J., Smith B.D. The RFX family interacts at the collagen (COLIA2) start site and represses transcription. J. Biol. Chem. 2002, 277:24926-24937.
446. Wright E., Hargrave M.R., Christiansen J., Cooper L., Kim J., Evans T., Gangadharam U., Greenfield A., Koopman P. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 1995, 9:15-20.
447. Zhao Q., Eberspaecher H., Lefebvre V., de Crombrugghe B. Parallel expression of Sox9 and Co12a1 in cells undergoing chondrogenesis. Dev. Dyn. 1997, 209:377-386.
448. Ng L.J., Wheatley S., Muscat G.E., Conway-Campbell J., Bowles J., Wright E., Bell D.M., Tam P.P., Cheah K.S., Koopman P. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 1997, 183:108-121.
449. Foster J.W. Mutations in SOX9 cause both autosomal sex reversal and campomelic dysplasia. Acta Paediatr. Jpn. 1996, 38:405-411.
450. Giese K., Page J., Grosschedl R. Distinct DNA-binding properties of the high mobility group domain of murine and human SRY sex-determining factors. Proc. Natl. Acad. Sci. USA 1994, 91:3368-3372.
451. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell Biol. 1997, 17:2336-2346.
452. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., Sham M.H., Koopman P., Tam P.P., Cheah K.S. SOX9 directly regulates the type-II collagen gene. Nat. Gen. 1997, 16:174-178.
453. Huang W., Zhou X., Lefebvre V., de Crombrugghe B. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX's ability to transactivate a Co12a1 chondrocyte-specific enhancer. Mol. Cell Biol. 2000, 20:4149-4158.
454. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox 9 is required for cartilage formation. Nat. Genet. 1999, 22:85-89.
455. Lefebvre V., Behringer R.R., de Crombrugghe B. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 2001, 9(Suppl A):S69-S75.
456. Joyce M.E., Roberts A.B., Sporn M.B., Bolander M.E. Transforming growth factor-? and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol. 1990, 110:2195-2207.
457. Redini F., Galera P., Mauviel A., Loyau G., Pujol J.P. Transforming growth factor ? stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett. 1988, 234:172-176.
458. Galera P., Vivien D., Pronost S., Bonaventure J., Redini F., Loyau G., Pujol J.P. Transforming growth factor-beta 1 (TGF-beta 1) up-regulation of collagen type 11 in primary cultures of rabbit articular chondrocytes (RAC) involves increased mRNA levels without affecting mRNA stability and procollagen processing. J. Cell Physiol. 1992, 153:596-606.
459. Pujol J.P., Galera P., Pronost S., Boumediene K., Vivien D., Macro M., Min W., Redini F., Penfornis H., Daireaux M. Transforming growth factor-beta (TGF-beta) and articular chondrocytes. Ann. Endocrinol. (Paris) 1994, 55:109-120.
460. Chadjichristos C., Ghayor C., Herouin J.F., Ala-Kokko L., Suske G., Pujo I.J.P., Galera P. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. J. Biol. Chem. 2002, 277:43903-43917.
461. Bradham D.M., Wiesche B., Precht P., Balakir R., Horton W. Transrepression of type II collagen by TGF-beta and FGF is protein kinase C dependent and is mediated through regulatory sequences in the promoter and first intron. J. Cell Physiol. 1994, 158:61-68.
462. Chen P., Carrington J.L., Hammonds R.G., Reddi A.H. Stimulation of chondrogenesis in limb bud mesodem cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor ?1 and ?2. Exp. Cell. Res. 1991, 195:509-515.
463. Pizette S., Niswander L. BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev. Biol. 2000, 219:237-249.
464. Hanada K., Solchaga L.A., Caplan A.I., Hering T.M., Goldberg V.M., Yoo J.U., Johnstone B. BMP-2 induction and TGF-beta 2 modulation of rat periosteal cell chondrogenesis. J. Cell Biochem. 2001, 81:284-294.
465. Shukumami C., Ohta Y., Sakuda M., Hiraki Y. Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. Exp. Cell Res. 1998, 241:1-11.
466. Valcourt U., Ronziere M.C., Winkler P., Rosen V., Herbage D., Mallein-Gerin F. Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Exp. Cell Res. 1999, 251:264-274.
467. Ahrens M., Ankenbauer T., Schroder D., Hollnagel A., Mayer H., Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol. 1993, 12:871-880.
468. Hatakeyama Y., Nguyen J., Wang X., Nuckolls G.H., Shum L. Smad signaling in mesenchymal and chondroprogenitor cells. J. Bone Joint Surg. Am. 2003, 85-A(Suppl 3):13-18.
469. Leboy P.S., Sullivan T.A., Nooreyazdan M., Venezian R.A. Rapid chondrocyte maturation by serum-free culture with BMP-2 and ascorbic acid. J. Cell Biochem. 1997, 66:394-403.
470. Volk S.W., D'Angelo M., Diefenderfer D., Leboy P.S. Utilization of bone morphogenetic protein receptors during chondrocyte maturation. J. Bone Miner. Res. 2000, 15:1630-1639.
471. Drissi M.H., Li X., Sheu T.J., Zuscik M.J., Schwarz E.M., Puzas J.E., Rosier R.N., O'Keefe R.J. Runx2/Cbfal stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J. Cell Biochem. 2003, 90:1287-1298.
472. Benya P.D., Shaffer J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype. Cell 1982, 30:215-224.
473. Dietz U., Aigner T., Bertling W., von der Mark K. Alterations of collagen mRNA expression during retinoic acid induced chondrocyte modulation: Absence of untranslated alpha(I) mRNA in hyaline chondrocytes. J. Cell Biochem. 1993, 52:57-68.
474. Benya P., Padilla P.D. Modulation of the rabbit chondrocyte phenotype by retinoic acid terminates type II collagen synthesis without inducing type 1 collagen: The modulated phenotype differs from that produced by subculture. Develop. Biol. 1986, 118:296-305.
475. Paulsen D.F., Langille R.M., Dress V., Solursh M. Selective stimulation of in vitro limb-bud chondrogenesis by retinoic acid. Differentiation 1988, 39:123-130.
476. Pacifici M., Golden E.B., Iwamoto M., Adams S.L. Retinoic acid treatment induces type X collagen gene expression in cultured chick chondrocytes. Exp. Cell Res. 1991, 195:38-46.
477. Lee G.S., Kochhar D.M., Collins M.D. Retinoid-induced limb malformations. Curr. Pharm. Des. 2004, 10:2657-2699.
478. Cho S.H., Oh C.D., Kim S.J., Kim I.C., Chun J.S. Retinoic acid inhibits chondrogenesis of mesenchymal cells by sustaining expression of N-cadherin and its associated proteins. J. Cell Biochem. 2003, 89:837-847.
479. Luyten F.P., Hascall V.C., Nissley S.P., Morales T.I., Reddi A.H. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem. Biophys. 1988, 267:416-425.
480. Loeser R.F., Todd M.D., Seely B.L. Prolonged treatment of human osteoarthritic chondrocytes with insulin-like growth factor-1 stimulates proteoglycan synthesis but not proteoglycan matrix accumulation in alginate cultures. J. Rheumatol. 2003, 30:1565-1570.
481. Somal D. Prevention of IGF-1 and TGFbeta stimulated type II collagen and decorin expression by bFGF and identification of IGF-I mRNA transcripts in articular chondrocytes. Matrix Biol. 2001, 20:233-242.
482. Wroblewski J., Edwall-Arvidsson C. Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J. Bone Miner. Res. 1995, 10:735-742.
483. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., Tabin C.J. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996, 273:613-622.
484. Vortkamp A. The Indian hedgehog-PTHrP system in bone development. Ernst. Schering Res. Found Workshop 2000, 191-209.
485. Weir E.C., Philbrick W.M., Amling M., Neff L.A., Baron R., Broadus A.E. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc. Natl Acad. Sci. U.S.A. 1996, 93:10240-10245.
486. Amizuka N., Warshawsky H., Henderson J.E., Goltzman D., Karaplis A.C. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol. 1994, 126:1611-1623.
487. Iwamoto M., Jikko A., Murakami H., Shimazu A., Nakashima K., Takigawa M., Baba H., Suzuki I., Kato Y. Changes in parathyroid hormone receptors during chondrocyte differentiation. J. Biol. Chem. 1994, 269:17245-17251.
488. Crabb I.D., O'Keefe R.J., Puzas J.E., Rosier R.N. Differential effects of parathyroid hormone on chick growth plate and articular chondrocytes. Calcif. Tissue Int. 1992, 50:61-66.
489. Goldring M., Birkhead J., Sandell L., Kimura T., Krane S. Interleukin 1 supresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J. Clin. Inv. 1988, 82:2026-2037.
490. Goldring M.B., Fukuo K., Birkhead J.R., Dudek E., Sandell L.J. Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. J. Cell Biochem. 1994, 54:85-99.
491. Goldring M.B., Birkhead J.R., Suen L.F., Yamin R., Mizuno S., Glowacki J., Arbiser J.L., Apperley J.F. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 1994, 94:2307-2316.
492. Pinnell S.R. Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J. Biol. Med. 1985, 58:553-559.
493. Schwarz R.I. Procollagen secretion meets the minimum requirements for the rate-controlling step in the ascorbate induction of procollagen synthesis. J. Biol. Chem. 1985, 260:3045-3049.